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Abstract
Multiple sclerosis is a chronic, neurodegenerative disease characterized
by inflammation and demyelination of the central nervous system that leads to
impaired coordination, muscle strength, and sensation. Balance and postural
control deficits are common in people with multiple sclerosis (PwMS) as 50%
will fall in any three-month period. Clinical exams have evolved to include
functional assessments such as the 30-second chair stand test (30CST) to evaluate
balance, fall risk and provide insight into functional mobility. However,
psychometric properties are limited and there remain gaps for statistically
characterizing change over time and generalizing performance to daily life.
While advances in wearable sensor technology allow for longer term monitoring
and biomechanical analysis outside the clinic, our methods for integrating
contextual information from daily life to identify people at risk for falls and
preemptively intervening before a fall occurs remain suboptimal. The work
herein is focused on developing quantitative biomarkers of impairment and fall
risk using wearable sensor data captured during sit-to-stand (STS) transitions
and represents a comprehensive evaluation of the STS during structured (30CST)
and unstructured tasks in supervised and unsupervised (daily life) settings.
Triaxial accelerometer data were collected for 40 PwMS from two
wearable sensors during supervised and unsupervised monitoring periods.
PwMS completed 30CSTs during supervised visits then participated in two days
of unsupervised monitoring in which they performed bi-hourly 30CSTs. An
automated algorithm was developed to process raw accelerometer data and
delineate the STS into regions of interest. Accelerometer-derived performance
metrics were developed and evaluated for their ability to classify fall risk, and
impairment through multiple techniques. First, metrics derived from supervised
30CSTs were used to inform machine learning models to classify fall risk and
model performance was compared to models trained on current standards of
care. Then unsupervised 30CST performance was compared to supervised
performance and performance variability was characterized. Finally, STS
transitions were identified during daily life and associated metrics were
compared to 30CST metrics to classify fall risk. The feasibility of using metrics to
discriminate pyramidal and sensory impairment was also explored.
The metric that best discriminated high and low fall risk was the average
sit-stand time from daily life STS transitions (AUC=0.85 vs AUC=0.69 for the
current standard of care). A threshold of 13 repetitions was proposed to identify
PwMS at high risk for falls in the clinic using the 30CST. While unsupervised
STS metrics optimized fall risk classification, supervised 30CST metrics best
classified high/low pyramidal impairment (AUC=0.85) and only supervised
30CST features classified high/low sensory impairment. This work underscores
the benefits of instrumented analysis for both structured and daily life tasks as
well as short bouts of unsupervised monitoring to inform clinical decision
making. Future work should build on these findings to improve the clinical
adoption of wearable sensors for patient monitoring and explore physiological
significance of performance metrics to inform personalized intervention.
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Chapter 1: Introduction
1.1 Multiple Sclerosis Overview
Multiple sclerosis (MS) is a progressive, degenerative neurological disease
characterized by inflammation, demyelination and axonal loss of the central
nervous system that affects approximately 2.2 million worldwide [1]. MS is twice
as common in women and prevalence increases according to distance from the
equator (1.03 times per degree of latitude) with a mean age of onset between 28 to
31 years [1–3]. While the specific cause of MS is unknown it is thought that genetic
and environmental factors elevate the risk for autoreactive lymphocytes to initiate
an immune-mediated inflammatory disorder that progresses to microglial
activation and chronic neurodegeneration in later stages [3,4]. There are two core
MS phenotypes, relapsing-remitting and progressive disease with clinical
subtypes including: clinically isolated syndrome which represents the first acute
inflammatory event, relapsing-remitting MS (85-90% of cases at onset), secondary
progressive MS (preceded by relapsing-remitting) and primary progressive MS
(10% of cases at onset) [5].
MS is a heterogenous disease as the pattern of symptoms for each patient is
dependent on the site(s) of brain and/or spinal cord demyelination (plaques)
(Figure 1) resulting from relapses, defined as episodes of acute demyelination
followed by complete or partial recovery. MS progresses as damage accumulates
over time with recurrent exacerbations resulting in permanent damage and
worsening disability [2].

There are common signs and symptoms including

unilateral sensory deficits in the limbs and face, unilateral vision loss, diplopia,
gait disturbance, balance problems, electric-shock sensations of the neck, back and
1

limbs (Lhermitte sign), fatigue, heat sensitivity (Uhthoff phenomenon), motor
weakness, pain, cognitive dysfunction and bladder problems [1,2]. The median
time from disease onset to disability requiring ambulatory assistance is 28 years
and life expectancy is reduced in people with MS (PwMS) by 7-14 years [6,7].

a

b

Figure 1. Clinical MRI from study participants illustrating lesions in the brain and spinal
cord. Top panel (a): juxtacortical (high posterior), periventricular and subcortical lesions
shown on sagittal (left) and axial (right) FLAIR sequences. Bottom panel (b): posterior cord
lesion shown on a PD (proton density) sequence (left), seen in the right side of the cord on
an axial fast field echo sequence (right) (courtesy of Andrew Solomon, MD and Adam Ulano,
MD).
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1.2 Contributions to Balance Impairment and Fall Risk
Balance has been conceptualized as an interconnection of multiple
underlying systems (Figure 2) [8]. Evidence has been presented in PwMS for
impairment in multiple domains including delayed anticipatory and reactive
postural control, decreased and limited movement at the limits of stability,
impaired muscle strength (i.e., classified under biomechanical constraints, Figure
2) and impaired sensation, all of which lead to problems with balance and postural
control, especially during dynamic activities [9–15]. Functional balance in PwMS
is further negatively impacted by cognitive deficits (34%-65%) reflected by
difficulties in dual-tasking and fear of falling (60%) [10,16,17].

Biomechanical
Constraints

Sensory
Inputs

Stability
Limits

Balance

Reactive
Postural
Responses

Anticipatory
Postural
Adjustments

Figure 2. Balance conceptualized as multi-system integration [15].
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Falls are the leading cause of injury in older adults (> 65 years) with nearly
3 million non-fatal fall-related emergency department visits in 2018 accounting for
63% of all ED visits in this age group [18]. Approximately 30% of older adults fall
each year and the rate of falling has been outpacing the expected trend of the aging
population [19] with an average annual percentage increase of 5.3% in the rate of
fatal falls [20]. The risk for falls further increases for PwMS as approximately 50%
of all PwMS and 25% without observable clinical disability will experience a fall
in any three-month period [21–23] and greater than 50% of falls in PwMS result in
injury requiring medical attention [24,25]. Fall-related long-term morbidity poses
serious financial and logistical impacts to healthcare and caregivers [26]. The
Centers for Disease Control and Prevention recently established falls as a strategic
research priority and growth area [19], as identifying fall risk in the primary care
setting is instrumental to directing intervention and preventing falls and injury
among older adults, particularly older adults with neurological impairments. In a
meta-analysis of eight studies comprising 1,929 participants eighteen potential risk
factors were identified with increased risk for falls with varying levels of evidence
[27]. PwMS with a progressive MS classification were 1.98 times more likely to fall
than those with a relapsing-remitting classification and cognitive impairment
increased risk of falling by 1.28 times. Other risk factors supported in the literature
include balance impairment, use of mobility aids, spasticity, fatigue, gait
disturbance, incontinence, visual deficits and fear of falling [16,24,27–29].
Importantly, the authors emphasized the multifactorial nature of fall risk for
PwMS and the importance of considering secondary issues such as environmental
influences [27].
4

1.3 Barriers to Assessing for Fall Risk and Impairment
Assessing fall risk in the clinic is confounded by reliance on the accuracy of
patient reported symptoms between visits, that along with fall history are subject
to recall bias [30,31]. Prognostic bias by the clinician may be introduced
unintentionally by implicitly assuming that the “snapshot” of physical functioning
measured and observed during the routine exam using the tools currently
available represent daily life [32]. PwMS are particularly susceptible to symptom
fluctuation, exacerbated by stress and fatigue, which directly impacts functional
mobility, implying that fall risk also varies [33–36].
Although contributions to balance impairment and fall risk are
multifactorial [37–39] clinicians are limited by the equipment and time available
to conduct comprehensive, complex assessments [40]. Thus, they often rely on
patient reported outcomes or standardized functional assessments to screen for
fall risk and direct intervention [39,41,42]. In particular, quick assessments
requiring minimal equipment, such as repeated chair stand tests, the Timed 25
Foot Walk (T25W), or the Timed Up and Go (TUG), lend themselves readily to
outpatient and community-based settings [43,44]. While these tests inherently
require postural control to maintain balance during transitions or gait and could
theoretically provide deeper insight into specific contributions to balance deficits,
clinicians are limited to interpreting results based on gross measures of
performance such as completion time or number of repetitions. Additionally, an
evaluation of multiple standardized functional assessments of balance (e.g., TUG,
Berg Balance Scale, Four Square Step Test) reflected a maximum sensitivity of 0.56
to predict future falls [27]. These tests have other notable limitations, such as
5

determining how to evaluate if change over time is statistically meaningful,
limited psychometric properties allowing for generalizability across different
patient populations, difficulty ascertaining specific contributions to mobility
impairment, and inadequate understanding of how a “snapshot” of physical
functioning relates to overall risk for falls, especially in neurological populations
where fluctuating symptoms are prevalent [36,45,46]. While clinicians acquire a
wide variety of skills to deliver interventions and compensatory approaches to
improve functional mobility, the tools to precisely diagnose mobility dysfunction
and objectively quantify change over time remain non-optimal.

1.4 The Sit-Stand Transition as a Biomarker
The ability to stand from a seated position, the sit-to-stand (STS) transition,
is a requirement for functional independence and a functionally demanding task
[47]. Biomechanically, the STS is characterized by a shift of the body center of mass
from forward to upward motion [48,49] (Figure 3). Initially horizontal linear
momentum of the body center of mass (COM) is generated primarily by rotational
motion of the trunk, then transitions to a vertically directed COM momentum as
trunk orientation changes from flexion to extension while the thighs
simultaneously accelerate the COM vertically (cranially) during hip and knee
extension [49,50]. While lower limb strength plays an important role in generating
the propulsive forces required for completing a STS transition, the STS also
requires precise coordination of muscle activation patterns of the lower extremity
and erector spinae musculature to stabilize the body center of mass as it transitions
from forward to upward motion [48]. Thus, successful completion of a STS
6

transition depends on the interplay of lower limb strength and postural control
mechanisms [51,52].

Figure 3. Average estimated horizontal to
vertical displacement of the center of mass
during a sit-to-stand transition (n=10 healthy
subjects). The vertical dotted line represents
the base of support (i.e., distance between the
feet) with the ankle joint as the origin of the
coordinate system [49].

STS biomechanics have been examined in PwMS in a limited capacity.
PwMS that exhibited lower extremity weakness compared to age-matched
controls (as measured by a one repetition maximum bilateral leg press test)
employed a trunk flexion strategy and increased sit-stand time averaged over five
trials separated by rest breaks in one study of [53]. An instrumented TUG
assessment comparing healthy controls to PwMS compared thigh and chest
gyroscope-derived features during the sit-stand and stand-sit transitions and
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concluded that sit-stand features derived from the thigh sensor were the most
informative for discriminating between groups [54].
The STS transition forms the basis for various standardized functional
assessments [52,55,56], and the repeated sit-to-stand paradigm in particular has
been shown to provide insight into functional strength [57], balance deficits and
fall risk for multiple patient populations [51,58]. The 30-second chair stand test
(30CST) [57] requires the participant to perform repeated STS repetitions for 30
seconds, and the number of repetitions performed serves as the primary outcome
measure [59]. The 30CST has been well studied in geriatric populations to establish
healthy normative data for community dwellers [60] and to approximate lower
extremity strength [57,59] in older adults; however, it has not been used to classify
fallers nor to characterize balance impairment in PwMS.

1.5 Wearable Sensor Use in Supervised and Unsupervised Settings
The utility of wearable sensors has been established for biomechanical and
gait analyses and longer-term activity monitoring in research settings [61,62]. As
wearable sensors are portable and inexpensive, they are drastically changing the
paradigm to allow for detailed biomechanical analyses of movement and
performance in the community setting. Multiple studies have demonstrated that
augmenting standardized functional assessments (i.e., TUG [54,63,64] and FiveTime Sit-to-Stand (5xSTS) [65,66]) with accelerometer-derived measures improves
the discriminative ability to detect group differences compared to the gross outcome measures, however no study has assessed the potential benefits of an
instrumented 30CST.
8

A growing body of evidence comparing laboratory to daily life
performance using wearable sensors has revealed that measurements from
supervised settings may not directly translate to mobility impairment during daily
life [112,120,120–123]. Many recent studies have evaluated gait characteristics for
people with neurological impairment and healthy controls in both supervised and
unsupervised settings and concluded that metrics that discriminate between
groups differ by setting [67–72]. Additionally, ambulation while dual-tasking in
laboratory settings appears more representative of gait quality during daily life in
older adults [71] and PwMS [69]. Gait characteristics have also been used to
discriminate fallers and non-fallers in terms of retrospective and prospective falls
in older adults [73,74].
Two previous groups have identified daily life transitions with wearable
sensors and used task characteristics to discriminate people with Parkinson’s
Disease (PwPD) and healthy older adults [75,76]. One group identified sit-towalking and walking-to-sit (but not sit-to-stand, stand-to-sit) as their primary
tasks through an activity classification approach to identify episodes of walking
and episodes of sitting, then analyzed the timeframe between those episodes for
potential transitions [76].

They computed performance metrics from triaxial

gyroscopic and accelerometer signals and used a machine learning approach to
discriminate between PwPD with mild and severe disease, and PwPD from
healthy older adults.

Another group used a continuous wavelet transform

technique to identify possible sit-stand (but not stand-sit) transitions during
laboratory-based sit-stand transitions during the 5xSTS and during daily life
transitions. They compared the ability of a small set of performance features to
9

discriminate PwPD from healthy young and older adults in the laboratory and
during daily life and reported AUC as their primary indicator of feature
discriminative ability [75]. While performance metrics of sit-stand transitions
identified during daily life have been shown to discriminate between groups
(neurological vs healthy controls) in these studies [75,76], no previous study has
directly compared supervised and unsupervised performance of sit-to-stand and
stand-to-sit transitions to discriminate fall risk in PwMS nor compared daily life
performance to a structured task (i.e., 30CST) to investigate specific contributions
to impairment and fall risk.

1.6 Approach
1.6.1 MS dataset
The data used for all analyses presented in this dissertation were collected
as part of a longitudinal study in PwMS to investigate the use of wearable sensor
data during common standardized clinical assessments (including the 30CST) and
activities of daily living to understand risk factors for falls. Data were collected for
n=40 PwMS dichotomized by fall history (n=20 reporting no falls in the previous
6-months, and n=20 reporting at least one fall in the previous 6-months).
Participants were recruited from the neurology department at the University of
Vermont Medical Center with the following inclusion/exclusion criteria:
independent mobility without use of assistive devices, no acute exacerbations
within

the

past

3-months,

no

other

neurological

impairments

or

cardiovascular/major health events, no history of chronic pain or recent
orthopedic procedures. The experimental protocol was approved by the
10

University of Vermont IRB and all participants provided informed consent. The
experimental protocol consisted of a supervised visit in the mSense Research
Laboratory located at University of Vermont within the College of Engineering
and Mathematical Sciences and an unsupervised portion lasting approximately
48-hours following the supervised visit.
1.6.2 Supervised laboratory session
Following consent, a neurologist administered the expanded disability
status scale (EDSS) to quantify disease severity. Participants then completed
clinical outcome measures including the Modified Fatigue Impact Scale
(MFIS)[77], the Activities-Specific Balance Confidence scale (ABC) [78] and the
Falls, Trips and Slips Survey. These were selected because they have previously
been related to fall risk [79,80]. Participants were classified as fallers if they had
sustained at least one fall in the previous 6-months. Participants were then
instrumented with commercially available wearable sensors (BioStamp nPoint,
MC10,

Inc.)

capable

of

measuring

accelerometer,

gyroscopic

and

electromyographic (EMG) data placed bilaterally on the dorsal foot, shank and
thigh, as well as the sternum and lumbar spine. While instrumented, participants
performed a series of standardized functional assessments common to clinical
practice for quantifying functional strength, balance and fall risk, including TUG,
30CST, T25W and balance challenging activities. A static standing posture was
collected in which participants were instructed to stand as tall as possible with
their shoulders retracted and feet facing forward.

11

1.6.3 Unsupervised (daily life) monitoring
Following the laboratory data collection session, sensors were removed and
replaced by a subset of sensors (right thigh, sternum and right foot) programmed
to collect only accelerometer data for the next 48 hours. Participants were also
provided a mobile phone to interface with an application (i.e., MC10 Link App) to
collect subjective ratings of their balance confidence, fatigue and fall status, as well
as facilitate an objective functional assessment (i.e., 30CST) every two waking
hours. Figure 4 illustrates an example of raw thigh accelerometer data collected
from two separate unsupervised 30CST performed during the same day for one
participant.

Figure 4. Example of thigh accelerometer data from one participant
performing an unsupervised 30CST at two time points during the
day. Note the data represent raw acceleration signals not yet
calibrated to a standing pose. The top 30CST represents a
performance of 13 sit-stand transitions while the bottom represents
a performance of 9 sit-stand transitions.
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1.7 Conclusions and dissertation outline
This literature review provides the overview of disease burden that leads
to balance impairment and elevated fall risk in PwMS and describes tools and
technologies available to provide more comprehensive assessment. Technologies
are changing some aspects of the U.S. healthcare paradigm to a proactive,
individualized model of care, yet sensitivity for detecting people at risk for falls
continues to be non-optimal. There is a need for both improving the ability to
detect people at risk for falls and earlier deployment of interventions to address
fall risk prior to a fall occurring.
The 30CST has been well studied in geriatric populations to establish
healthy normative data for community dwellers [60] and to approximate lower
extremity strength [57,59]; however, it has not been used to classify fallers,
establish recommended thresholds for identifying fall risk in the clinic in any
population, or to characterize impairments related to balance deficits in
neurological populations. There are no previous studies indicating that any sitstand derived functional assessment has been sufficiently characterized to
understand its ecological validity. Validation studies for functional assessments
have at most consisted of a test-retest paradigm on two different days [57,81],
presumably to satisfy the criteria to compute the minimal detectable change
(MDC) [46], with no previous study assessing unsupervised performance
throughout the day in any population. Thus, there is limited understanding as to
how performance during functional assessments generalize to daily life, including
neurological populations where symptoms, and thus fall risk, fluctuate [45].
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Wearable sensor technology has developed to the point that it could be
incorporated into routine primary care visits to establish a new paradigm of multiday monitoring to assess symptom, and thus fall risk, fluctuation. Yet there remain
barriers to clinical adoption of wearable sensors as a tool to augment clinical
decision making. Clinical adoption could be facilitated by developing and
validating simple, interpretable metrics that enhance the sensitivity of established
clinical tools to detect elevated fall risk and inform intervention strategies; thus,
all performance metrics developed in this body of work were limited to signal
characteristics with plausible physiological significance.
The overarching goal of this work has been to advance the use of
engineering tools to inform clinical decision making. The work herein focused on
developing quantitative biomarkers of impairment and fall risk using wearable
sensor data captured during sit-to-stand (STS) transitions and represents a
comprehensive evaluation of the STS during structured (30CST) and unstructured
tasks in supervised and unsupervised (daily life) settings. Chapter 2 describes a
novel algorithm that was developed to automate the 30CST and the entire
approach to evaluating the sit-stand and stand-sit transitions was developed in
this chapter. The algorithm for delineating the phases of the 30CST and developing
performance metrics for this initial exploration were developed using only a single
thigh sensor and the same methodology for discretizing sit-stand and stand-sit
transitions was utilized throughout the subsequent analyses. Chapter 3 provides
a comparative analysis of supervised and unsupervised 30CST performance.
Participants were asked to perform bi-hourly 30CST during the 48-hours of
unsupervised monitoring and this analysis pertains to characterizing the
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variability of 30CST performance. Metrics reflecting average unsupervised 30CST
performance were compared to supervised performance metrics and both sets of
metrics were assessed for their ability to classify fall risk. This analysis represented
a novel approach to characterizing variability of performance throughout the day
as opposed to the test/re-test paradigm performed by other groups. Chapter 4
describes a new method for identifying sit-stand and stand-sit transitions from the
daily life (unsupervised) monitoring that diverges from previous studies in
multiple ways. Importantly, our approach was based on identifying sitting
episodes and then investigating all periods of time directly prior and subsequent
to those sitting episodes for potential transitions. This allowed for identifying both
sit-to-stand and stand-to-sit transitions, capturing all potential transitions
regardless of the activity that immediately preceded or followed the sitting
episodes, and did not rely on an algorithm developed from supervised
(laboratory) based transitions (i.e., using transitions performed during a
standardized functional assessment) to identify daily life transitions. Temporal
and acceleration-related features of performance derived from chest and thigh
sensor data were then compared to 30CST metrics for their ability to classify fall
risk as well as pyramidal/sensory impairment. Chapter 5 provides a summary of
the contributions to the scientific community, a brief discussion of analyses that
were attempted but ultimately proved fruitless using this dataset, barriers to
clinical adoption, and implications for future work.
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Chapter 2: Metrics Extracted from a Single Wearable Sensor During Sit-Stand
Transitions Relate to Mobility Impairment and Fall Risk in People with
Multiple Sclerosis

2.1. Introduction
Multiple sclerosis is a degenerative neurological disease characterized by
inflammation, demyelination and axonal loss of the central nervous system that
leads to sensorimotor impairments affecting gait and balance. While disability
severity (as measured by the Expanded Disability Status Scale) is weighted toward
gait impairment in the middle to end range of the scale, even those with low
disability levels experience sensorimotor and balance deficits [82]. Approximately
two-thirds of PwMS report mobility problems [33]. As a result of these deficits,
falls are common with approximately half of the 2.3 million PwMS experiencing a
fall in any three-month period [21]. Although contributions to balance impairment
and fall risk are multi-factorial, clinicians are limited by the equipment and time
available to conduct complex assessments. Thus, they often rely on self-report or
standardized functional assessments to screen for fall risk and direct intervention
[39,41,42]. In particular, quick assessments requiring minimal equipment, such as
repeated chair stand tests, the Timed 25 Foot Walk (T25W), or the Timed Up and
Go (TUG), lend themselves readily to outpatient and community-based settings.
While these tests inherently require postural control to maintain balance during
transitions or gait and could theoretically provide deeper insight into specific
contributions to balance deficits, clinicians are limited to interpreting results based
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on gross measures of performance such as completion time or number of
repetitions.
The repeated sit-to-stand (STS) paradigm in particular has been shown to
provide insight into functional strength [83], balance deficits and fall risk for
multiple patient populations, (e.g., see including PwMS [51,58]). The STS is a
functionally demanding task [47] that elicits muscular fatigue when performed
repeatedly [84]. The 30-second chair stand test (30CST)[83] requires the participant
to perform repeated STS repetitions for 30-seconds, and the number of repetitions
performed serves as the primary outcome measure [59]. The 30CST has been well
studied in geriatric populations to establish healthy normative data for
community dwellers [60] and to approximate lower extremity strength [57,59];
however, it has not been used to classify fallers nor to characterize balance
impairment in PwMS. While lower limb strength plays an important role in
generating the propulsive forces required for completing a STS transition, the STS
also requires precise coordination of muscle activation patterns of the lower
extremity and erector spinae musculature to stabilize the body center of mass as it
transitions from forward to upward motion [48]. Thus, successful completion of a
STS transition depends on the interplay of lower limb strength and postural
control mechanisms [51,52]. Given that fatigue and balance problems are two of
the most commonly reported symptoms in PwMS [85,86], this type of assessment
seems particularly suited to characterizing balance deficits and fall risk in PwMS.
The utility of wearable sensors has been established for biomechanical and
gait analyses and longer-term activity monitoring in research settings for PwMS
(see reviews [87,88]). They are portable and inexpensive, and thus have the
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potential to provide clinicians with detailed performance data. Clinical translation
could be enhanced by initial efforts focused on translating research findings into
simple metrics that augment assessments and can be used to inform clinical
decision making. Establishing correlation between validated clinical tools and
accelerometer-based metrics may facilitate clinical adoption. Previous studies
have characterized the STS transition using wearable sensors and derived metrics
capable of discriminating between groups; however, these studies relied on the
gyroscope signal [54,66,89] which limits long-term deployment to the home
because of high power requirements [90]. Additionally, previous studies have not
explored the development of a statistical model to identify fall risk based on 30CST
performance in PwMS. Thus, the purpose of this study was to derive
accelerometer-based metrics from a minimal number of sensors to characterize
STS performance in PwMS during the 30CST. Metrics were used to explore (1) if
there was agreement with clinical outcome measures of disease severity, balance
confidence, and fatigue, (2) if they could be utilized to detect differences between
fallers and non-fallers, and (3) if they provided additional information to better
inform identification of fall status when compared to manually counted
repetitions from the 30CST.

2.2. Methods
2.2.1. Experimental design
Thirty-eight PwMS (21 fallers, inclusion: no major health conditions other
than MS, no acute exacerbations within the previous 3-months, ambulatory
without assistive devices) were recruited from the neurology department at the
18

University of Vermont Medical Center. The experimental protocol was approved
by the University of Vermont IRB and all participants provided informed consent.
A neurologist administered the expanded disability status scale (EDSS) to quantify
disease severity, and participants were classified as fallers if they had sustained at
least one fall in the previous 6-months. Participants completed clinical outcome
measures including the Modified Fatigue Impact Scale (MFIS)[77], and the
Activities-Specific Balance Confidence scale (ABC)[78]. These were selected
because they have previously been related to fall risk [79,80].
Triaxial accelerometer data (sample rate 250 Hz, ±16 g) were recorded from
inertial sensors (Biostamp, MC10, Inc., Lexington, MA) adhered directly to the skin
on the anterior right thigh and chest, which comprised a subset of sensors
deployed as part of a larger study. The participants performed a series of
functional assessments including one trial each of the 30CST, T25W, and TUG. The
30CST was performed using a standard height (17-inch) chair, and participants
were instructed to complete as many sit-to-stand transitions as possible with arms
crossed over their chest, as quickly and safely as they felt comfortable. Each
participant also performed a 30-second static standing trial with instructions to
maintain a tall posture with their feet facing forward.
2.2.2. Event detection algorithm
A fully automated Matlab algorithm (Mathworks, Natick MA) was used to
process the raw accelerometer data and derive the metrics of interest. Raw
accelerometer data were transformed into anatomically-relevant reference frames
using data from the static standing trial and methods adapted from [28]. This was
performed by projecting accelerometer data onto anatomical axes using the
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direction of gravity and the known sensor locations on the anterior aspect of the
chest and thigh to resolve the accelerometer signal in a reference frame with axes
approximately aligned with the cranial-caudal (CC), anterior-posterior (AP) and
medial-lateral (ML) directions (Figure 5a). This convention was maintained
throughout the analysis, but it should be noted that while the CC component was
aligned with gravity during the standing calibration, the CC component is fixed
in the thigh and will thus represent an AP-directed acceleration at the onset of the
sit-to-stand transition (i.e. while the thigh is horizontal). Sit-to-stand (si-st) and
stand-to-sit (st-si) transition phases (see Figure 5) were determined by locating the
stand (solid gray line in Figure 5b) and sit (solid black line in Figure 5b) events
during the task. The stand and sit events were identified as the maximum and
minimum values, respectively, in the CC component of the thigh accelerometer
signal that had been low-pass filtered using a 3rd order Butterworth IIR filter with
a cutoff frequency equal to the dominant frequency observed during the 30CST
(Figure 5b). This filtering approach isolates accelerometer signal content related to
the changes in body segment orientation characteristic of the STS task. Sit and
stand events were used to compute sit-stand duration (si-st time) and the standsit duration (st-si time) for each transition. Chest accelerometer data were low-pass
filtered in the same way to isolate the gravitational acceleration of the CC and AP
components of the trunk and trunk flexion angles were approximated throughout
the task using a method adapted from [91,92]. Briefly, flexion was computed as
the arctangent of the ratio of the AP and CC components of the gravitational
acceleration.
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Figure 5: Overview of the algorithm for identifying and extracting accelerometer-derived
metrics from a single thigh sensor during a portion of the 30CST. Raw triaxial accelerometer
data (a) was transformed into the anatomically relevant reference frame (right) using the
direction of gravity to align the z-axis (CC component). The CC component of the signal was
low pass filtered (b) to identify sit (solid black line), stand (solid gray line), and inflection points
(dotted lines) to isolate four phases during the sit-stand-sit transitions. Raw accelerometer data
were then bandpass filtered (c) and used to extract peaks (indicated by circles) in the identified
regions of interest.

The si-st and st-si phases were further delineated (four phases total, Figure
5b) to reflect the change from AP to CC directed movement mid-transition [48],
and to isolate the initiation of the si-st transition (lift-off phase, Figure 5c) and the
portion of the st-si phase immediately preceding the sit phase during eccentric
control, including the final forward lean [93] to touch down (touch-down phase,
Figure 5c). As illustrated in Figure 5 these events were located for each transition
by identifying the inflection points, computed by taking the maximum and
minimum of the derivative of the low-pass filtered CC accelerometer signal, which
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corresponded to the sit-to-stand (gray dashed line) and stand-to-sit (black dotted
line) events, respectively. Peak thigh accelerations were extracted in the four
phases (absolute maximum) from raw accelerometer signals bandpass filtered
using a 3rd-order Butterworth IIR filter with cutoff frequencies of 5 and 20Hz.
These cutoffs were selected to limit signal content to a physiologically relevant
range while also removing the effects of changes in sensor orientation.
2.2.3. Task performance metrics
Metrics for characterizing task performance included the number of
repetitions (automatically computed from thigh accelerometer data) and the mean
and coefficient of variation (CV) of each accelerometer-derived measure extracted
from each STS repetition completed during the 30CST by each participant
described above. These measures were the si-st time and the st-si time (4 features),
peak CC, AP and ML acceleration of the thigh during the four phases (24 features),
and peak trunk flexion during the si-st and st-si phases (4 features).
2.2.4. Statistical analysis
Independent sample t-tests and Wilcoxon Rank Sum Tests (for non-normal
variables determined via Kolmogorov-Smirnov test) were used to evaluate
differences between fallers and non-fallers for all clinical outcome measures and
accelerometer-derived metrics.
Supervised machine learning was used to train logistic regression models
for classifying participant fall status based on accelerometer-derived metrics.
Model performance was established using leave-one-subject-out cross validation
(LOSO-CV). In this approach data from all but one subject were partitioned into a
training set, features that best discriminated between fallers and non-fallers were
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selected via Davies-Bouldin feature selection, and a model was trained to predict
the fall status of the held-out subject. This process was repeated until fall status
had been predicted for each subject. To provide context, the performance of the
accelerometer-based model was compared to models trained to classify fall status
based on clinical features (ABC score, number of 30CST repetitions, TUG time and
T25W time). Model performance was primarily assessed by considering the area
under the receiver operating characteristic curve (AUC), but model accuracy,
sensitivity, and specificity for a posterior probability threshold of 0.5 were also
computed.
Finally, Spearman correlations were used to evaluate the relationship
between accelerometer-derived metrics and clinical measures of disease severity
(EDSS), balance confidence (ABC) and fatigue (MFIS). Correlation strength was
interpreted as per [94]. Effect size was evaluated for all metrics demonstrating
statistically significant differences using the Cohen’s d statistic (d). All statistical
analyses were performed in SPSS (SPSS Inc., Chicago, IL).

2.3. Results
Fallers and non-fallers demonstrated statistically significant differences in
age (p=0.006, d=0.0.87), EDSS (p=0.006, d=0.88), ABC (p=0.001, d=1.00) and MFIS
(p=0.01, d=0.82) (Error! Reference source not found.). We also found a statistically
significant difference between fallers and non-fallers for 30CST (p=0.003, d=0.88),
T25W (p = 0.024, d=0.74) and TUG (p = 0.006, d=0.67) performance. As for the
acceleration derived metrics, we detected differences between the groups for mean
si-st time (p=0.005, d=0.93), mean st-si time (p=0.004, d=0.91), CV st-si time
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(p=0.001, d= 0.63), mean peak CC thigh acceleration during the si-st transition
(p=0.007, d=0.85), mean peak CC thigh acceleration during the st-si transition
(p=0.035, d=0.68) and mean peak AP thigh acceleration during the st-si transition
(p=0.037, d=0.67) (Error! Reference source not found.).

Table 1. Characteristics of participants and accelerometer derived metrics
Participant
Characteristic/Metric
Clinical Metrics
Age (yrs)
EDSS
MFIS
ABC
30CST (# reps)
T25W (s)
TUG (s)
Accelerometer Derived Metrics
Mean si-st time (s)
Mean st-si time (s)
CV st-si time
Avg peak CC si-st (1) accel (g)
Avg peak CC st-si (1) accel (g)
Avg peak AP st-si (1) accel (g)

Cohort
Mean ± SD

Fallers
Mean ± SD

Non-Fallers
Mean ± SD

p

d

50.6 ± 12.1
2.9 ± 1.3
35.6 ± 17.6
81.9 ± 18.0
11.6 ± 3.1
5.8 ± 1.4
9.2 ± 2.5

55.3 ± 8.6
3.4 ± 1.2
42.3 ± 14.3
73.7 ± 19.4
10.4 ± 2.7
6.2 ± 1.5
10.0 ± 2.3

44.8 ± 13.5
2.3 ± 1.2
27.8 ± 18.2
91.5 ± 9.2
13.1 ± 3.0
5.2 ± 1.0
8.3 ± 2.6

0.006
0.006
0.01
0.001
0.003
0.024
0.006

0.87
0.88
0.82
1.00
0.88
0.74
0.67

1.35 ± 0.33
1.38 ± 0.36
0.06 ± 0.05
0.17 ± 0.10
0.11 ± 0.06
0.18 ± 0.11

1.49 ± 0.34
1.52 ± 0.38
0.08 ± 0.06
0.13 ± 0.08
0.10 ± 0.06
0.15 ± 0.08

1.18 ± 0.23
1.19 ± 0.24
0.05 ± 0.02
0.21 ± 0.10
0.13 ± 0.06
0.22 ± 0.13

0.005
0.004
0.001
0.007
0.035
0.037

0.93
0.91
0.63
0.85
0.68
0.67

P-values are based on independent sample T-test (or Wilcoxon Rank Sum Tests when the test
for normality was violated) and effect sizes were evaluated using Cohen’s d. Clinical measures
include Expanded Disability Status Scale (EDSS), Modified Fatigue Impact Scale (MFIS),
Activity Balance Confidence (ABC), 30-Second Chair Stand Test (30CST), Timed 25 Foot Walk
(T25W) and the Timed Up and Go (TUG).

Model performance for a logistic regression model based only on clinical
outcome measures was highest for the ABC as the sole model feature (Table 2,
Model 1) with an AUC of 0.75 and accuracy of 71%. The functional assessment
gross performance measure that best classified falls status was the 30CST number
of repetitions, which outperformed both the TUG and T25W (Table 2, Models 224

4). Of the 32 accelerometer derived metrics, three metrics were chosen within each
iteration of the LOSO-CV to include in the accelerometer feature only driven
model. The accelerometer features that optimized model performance were a
combination of acceleration and temporal features with information from both sist and st-si transition phases (si-st time, st-si time, and mean peak CC si-st (1) accel)
and yielded model accuracy of 74% with an AUC of 0.77 (Table 2, Model 5). When
all possible clinical outcome measures and accelerometer metrics were combined,
the features selected within the LOSO-CV were the ABC and the same three
accelerometer features, resulting in a slight improvement in AUC, but not
accuracy (Table 2, Model 6). Model features selected by LOSO-CV were chosen
for ³90% of the LOSO iterations.
Table 2. Classification performance for logistic regression models comparing model features
from clinical outcome measures and accelerometer derived metrics.
Model

AUC

Acc

Sens

Spec

Parameters

1
2
3
4
5

0.75
0.74
0.65
0.63
0.77

0.71
0.68
0.66
0.62
0.74

0.71
0.81
0.62
0.56
0.81

0.71
0.53
0.71
0.59
0.65

6

0.78

0.71

0.71

0.71

ABC
30CST performance (reps)
TUG performance (s)
T25W performance (s)
Avg si-st time, avg st-si time, avg peak CC si-st (1) accel
ABC, avg si-st time, avg st-si time, avg peak CC si-st (1)
accel

ABC: Activity Balance Confidence scale, 30CST: 30-Second Chair Stand test, TUG: Timed Up and Go,
T25W: Time 25-foot walk, si-st (1): first half of sit-to-stand, st-si (1): first half of stand-to-sit, CC:
cranial-caudal, AUC: area under the curve, Acc: accuracy, Sens: sensitivity, Spec: specificity. Model
features were chosen for inclusion based on a leave-one-subject-out (LOSO) cross-validation. All
parameters chosen by the LOSO validation were chosen for at least 90% of the test observations.

Multiple accelerometer derived metrics from a single thigh sensor
moderately correlated to all three clinical outcome measures: EDSS, ABC and
MFIS (Table 3), including number of repetitions performed and all metrics selected
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for model inclusion through LOSO cross-validation (mean si-st time, mean st-si
time, and mean peak CC si-st (1) accel). All computed metrics demonstrating
statistically significant correlations are presented in Table 3.

Table 3. Statistically significant correlations (r) and the associated p-values (p) between
accelerometer derived metrics and clinical measures
EDSS

Metric
30CST (# reps)
Sit-to-Stand Metrics
Mean si-st time (s)
Mean peak CC si-st (1) accel (g)
Mean peak ML si-st (1) accel (g)
Mean peak ML si-st (2) accel (g)
Mean peak CC si-st (2) accel (g)
Stand-to-Sit Metrics
Mean st-si time (s)
CV st-si time (s)
Mean peak CC st-si (1) accel (g)
Mean peak ML st-si (1) accel (g)
Mean peak AP st-si (1) accel (g)

MFIS

ABC

p

r

p

r

p

r

p < 0.001

-0.56

0.005

-0.45

p < 0.001

0.54

p < 0.001
0.002
p < 0.001
0.024
0.035

0.56
-0.50
-0.58
-0.36
-0.34

0.006
p < 0.001
0.001
0.019
p < 0.001

0.44
-0.62
-0.52
-0.39
-0.56

p < 0.001
p < 0.001
p < 0.001
0.008
0.007

-0.54
0.58
0.55
0.42
0.43

0.001
0.026
0.001
0.009
0.001

0.53
0.36
-0.51
-0.42
-0.52

0.005
0.014
0.026
0.029
0.001

0.45
0.40
-0.37
-0.36
-0.52

0.001
0.01
0.013
0.018
0.004

-0.51
-0.41
0.40
0.38
0.45

Non-significant correlations not reported.Expanded Disability Status Scale (EDSS), Modified
Fatigue Impact Scale (MFIS), Activity Balance Confidence (ABC), 30-second chair stand test
(30CST), sit-to-stand transition (si-st), stand-to-sit transition (st-si), caudal-cranial (CC), anteriorposterior (AP), medial-lateral (ML), acceleration (accel)

2.4. Discussion
Wearable sensors are emerging as a new tool for quantifying biomechanics,
especially as they relate to balance and mobility dysfunction in PwMS
[87,88,95,96]. Their use to augment functional assessments like the 30CST can
provide clinicians with deeper insight into performance [54,89,97]. However, to
enable long term deployment in the community setting, there is a need for simple
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and interpretable metrics that enhance the sensitivity of common clinical tools to
detect elevated fall risk and inform intervention strategies. Herein, we characterize
the 30CST using a minimal number of wearable sensors and explore associations
with balance confidence, fatigue and disease severity in a sample of PwMS. We
show that biomechanically relevant metrics extracted from data recorded by a
single wearable accelerometer are correlated with clinically meaningful measures.
Performance of a logistic regression model to classify fallers with only
accelerometer-derived metrics was comparable to models with features consisting
only of clinical outcome measures and functional assessment gross performance
measures (see Table 2, Model 5 AUC, Accuracy and Sensitivity compared to
Models 1-4).
We demonstrated that the 30CST outperforms (Table 2, Model 2) other
functional assessments (Table 2, Models 3 and 4) in this cohort, suggesting that the
30CST might lend itself to discriminating between fallers and non-fallers in PwMS
by exacerbating balance deficits with muscular fatigue, thus impacting
performance.

Interestingly, the ABC outperforms all functional outcome

measures in terms of AUC and accuracy (Table 2, Model 1) for classifying fallers,
which is consistent with previous studies [98]; however, patient reported outcome
measures may not accurately quantify changes over time due to interventions [99],
thus limiting their utility for assessing the effectiveness of interventions to
improve balance and decrease fall risk in research studies and in the clinic. Taken
together, these findings suggest the 30CST may be especially useful for monitoring
balance impairment and fall risk in PwMS.

27

Generally, greater impairment in all domains (fatigue, balance, disease
severity) was reflected in decreased acceleration signatures in all components (AP,
CC and ML), and increased time to complete the transitions (see Table 3),
suggesting participants adopt a slower [53], more cautious strategy as they fatigue
and/or confidence in their balance is diminished. Increased CC acceleration at the
thigh, which was anteriorly directed at the onset of the si-st transition, might
reflect the importance of knee extensor strength for a successful sit-to-stand
transition, which is consistent in other studies of PwMS and total knee
arthroplasty [54,100].
The results presented herein demonstrate that a combination of temporal
and acceleration-derived features at specific phases of the sit-to-stand and standto-sit transitions compare favorably to the current outcome measure of the 30CST
for classifying fall status (see Table 2). One key difference in our study was the
derivation of features solely based on the accelerometer signal, obviating the need
for gyroscopes, which expands the applicability to community and home
monitoring. Additionally, these data suggest that a single thigh-worn sensor
would be sufficient for analyzing the 30CST. This creates exciting possibilities for
clinicians who may want to monitor the effectiveness of an intervention or
understand how fluctuating symptoms directly lead to changes in balance and
motor control. While counting the number of repetitions is quick and requires
minimal equipment, we have shown that including accelerometer features at
specific transition phases of interest improves the model’s ability to discriminate
fallers from non-fallers (Table 2). Practically, a single accelerometer could be made
readily available for quick measurements in clinical settings, or the model could
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be deployed as a mobile application that leverages the accelerometer inherent to
every smart phone. Alternatively, given that adults perform an average of 60 sitto-stands transitions per day [101], accelerometer metrics could be used to monitor
single sit-to-stand repetitions during daily life to inform acute fall risk.
While our study included a relatively small sample size, it was comparable
to similar studies that derived metrics from thigh and chest sensors to classify fall
status in the elderly [65] and PwMS [54]. Witchel et al [54] analyzed 819 features
from 40 participants (17 PwMS) using the gyroscope signal and compared results
from PwMS to healthy participants. Our feature set was limited to metrics that
could be related to physiological factors associated with performance, and in the
future might be informative for directing intervention. Despite our relatively small
feature set and generally lower cohort EDSS score, our accelerometer-derived
features from a single sensor were discriminatory for classifying falls, which
further supports our clinical goal of identifying people at risk for falling and
deploying interventions pre-emptively. These promising results point toward the
need for future validation of this model using motion capture in a larger sample
including greater disability to better understand how it will generalize to new
subjects. Future studies will include accelerometer data from unsupervised daily
life and longitudinal follow up data to understand if our metrics are sensitive to
changes over time and predictive of future falls for PwMS.
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Chapter 3: Evaluation of Unsupervised 30-Second Chair Stand Test
Performance Assessed by Wearable Sensors to Predict Fall Risk in Multiple
Sclerosis

3.1. Introduction
Multiple sclerosis is a chronic, neurodegenerative disease characterized by
inflammation and demyelination of the central nervous system that leads to
impaired coordination, muscle strength, and sensation [102]. Balance and postural
control deficits occur in over two-thirds of people with multiple sclerosis (PwMS)
across the spectrum of disability levels [103], and may occur prior to clinically
observable changes in functional mobility [104,105]. Fall risk for PwMS outpaces
that of the general aging population, with approximately 50% of all PwMS and
25% without observable clinical disability experiencing a fall in any three-month
period [23,106]. Prior studies have largely demonstrated bias toward PwMS at
higher disability levels, which may contribute to underestimating fall risk in
higher functioning patients [21,28].
Assessing fall risk in the clinic is confounded by reliance on the accuracy of
patient reported symptoms between visits, that along with fall history are subject
to recall bias [30]. Prognostic bias by the clinician may be introduced
unintentionally by implicitly assuming that the “snapshot” of physical functioning
measured and observed during the routine exam using the tools currently
available represent daily life [32]. PwMS are particularly susceptible to symptom
fluctuation, exacerbated by stress and fatigue, which directly impacts functional
mobility, implying that fall risk also varies [33–35,107]. While technological
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advances are transforming our medical paradigm in many areas with a shift
toward targeted, individualized therapies [108], our methodologies for identifying
people at risk for falls, integrating contextual information outside of the clinic, and
preemptively intervening before a fall occurs remain sub-optimal.
Clinical exams have evolved to include objective functional assessments to
evaluate balance, fall risk and mobility [43,44,109]. These assessments quickly
provide insight into physical functioning, typically require only simple
measurement tools such as a stopwatch and fit conveniently into a medical
paradigm that prioritizes efficiency. One such assessment, the 30-second chair
stand test (30CST), has been shown to provide insight into functional strength,
balance deficits and fall risk for multiple patient populations, including PwMS
[83,110,111]; however, psychometric properties have only been established for
older adults and people with osteoarthritis [112,113] and there remains a lack of
consensus for how to determine if change over time is statistically meaningful [46].
Additionally, there is limited understanding as to how performance on 30CST
assessments generalize to daily life, particularly in neurological populations with
fluctuating symptoms [107,114]. Advances in wearable sensors are fostering
longer-term activity monitoring and sophisticated biomechanical analysis outside
of the laboratory setting [61], and augmenting functional assessment with inertial
sensor metrics improves the sensitivity and discriminative ability to detect group
differences [64,65,111]. Thus, wearable sensors present a novel opportunity to
characterize performance of the 30CST in free-living conditions to better
understand generalizability of clinic-based observations.
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In this study we explore, for the first time, the completion of free-living
instrumented 30CSTs as a means for characterizing fall risk in PwMS. We sought
to compare supervised and unsupervised performance, in terms of both the
current standard of care (i.e., number of repetitions) and performance metrics
computed using accelerometer data, assess the variability of 30CST performance
during daily life and investigate the utility of wearable sensors for improving the
sensitivity to classify fall risk for both supervised and unsupervised performance
data.
3.2. Methods
3.2.1 Experimental design
Forty PwMS (inclusion: no major health conditions affecting balance other
than MS, no acute exacerbations within the previous 3-months, ambulatory
without assistive devices) were recruited from the University of Vermont Medical
Center Multiple Sclerosis Center. The experimental protocol was approved by the
University of Vermont IRB and all participants provided informed consent. Data
collection consisted of a supervised (laboratory) session immediately followed by
approximately 48-hours of unsupervised monitoring during free-living. During
the supervised visit a neurologist administered the expanded disability status
scale (EDSS) to quantify disease severity. Participants were classified as fallers if
they had sustained at least one fall in the previous 6-months where a fall was
characterized with the question: “consider a fall as an event where you
unintentionally came to rest on the ground or a lower level”. Additionally,
participants completed clinical outcome measures related to fall risk [79,80],
including the Modified Fatigue Impact Scale (MFIS) [77] and the Activities-Specific
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Balance Confidence scale (ABC) [78]. Triaxial accelerometer data (sample rate 250
Hz, ±16 g) were recorded from an inertial sensor (Biostamp, MC10, Inc., Lexington,
MA) adhered directly to the midpoint of the anterior right thigh approximately
aligned with the femur. The participants performed one trial of the 30CST using
a standard height (17-inch) chair in which they were instructed to complete sit-tostand transitions with arms crossed over their chest as quickly and safely as they
felt comfortable. Each participant also performed a 30-second static standing
calibration trial. Immediately following the supervised session, a new sensor was
placed on the right thigh in the same location for the unsupervised data collection
period. Prior to leaving the laboratory the participants were provided with a
smartphone and oriented to an application that interfaced with the MC10 sensors
(i.e., MC10 Link App) to capture responses to questionnaires and facilitate
unsupervised data collection.
Over the duration of the unsupervised portion of the study, participants
were asked to rate their symptoms of balance confidence and fatigue bi-hourly
using five point Likert scales [115] derived from the ABC and MFIS. Balance
confidence was evaluated with the question “In the last 2 hours, how confident
were you that you would not fall?” and the response choices were: “(1) Very
confident, (2) Confident, (3) Neutral, (4) Not Confident or (5) Very Not Confident”.
Similarly, participants were asked to rate fatigue with the question “In the last 2
hours, how often has fatigue prevented the completion of tasks that require
physical effort?” and the response choices were: “(1) Never, (2) Rarely, (3)
Sometimes, (4) Often or (5) Always.” Participants were then asked to perform a
30CST and record the number of repetitions they completed. An alarm was
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enabled on the smartphone at the requested task completion times (timeframe
07:00 to 21:00) to facilitate adherence. Participants were provided a handout with
instructions and another review of the 30CST technique using the smart phone
application, the type of chair to use and how the chair should be positioned against
a stable surface for safety. Only raw triaxial accelerometer data were collected by
the thigh sensor (62.5 Hz, ±16 g) during the unsupervised portion of the study.
Participants had to complete a minimum of four 30CST assessments during the
unsupervised period for inclusion in the analysis.
3.2.2 Data processing algorithm
The raw accelerometer data for all 30CSTs were processed using a fully
automated Matlab algorithm (Mathworks, Natick MA). The algorithm used only
the thigh accelerometer signal to delineate the sit-to-stand (si-st) and stand-to-sit
(st-si) phases of each 30CST repetition, compute the number of repetitions
performed for each 30CST and derive metrics to characterize performance. The
signal processing details have been previously reported [111]. Briefly, raw
accelerometer data were transformed into an anatomically relevant reference
frame using data from the static standing trial. The accelerometer signal was
projected onto the participant-specific thigh reference frame approximately
aligned with the anterior-posterior, medial-lateral and cranial-caudal directions
(Figure 6, right) using the known sensor location and the direction of gravity. Sist and st-si transition phases were determined by locating the stand and sit events
during the task, identified as the maximum and minimum values, respectively in
the cranial-caudal component of the thigh accelerometer signal that had been low
pass filtered using a 3rd order Butterworth IIR filter with a cutoff frequency equal
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to the dominant frequency observed during the 30CST. Sit and stand events were
used to compute si-st and st-si duration times Figure 6 for each transition and these
duration times were then used to compute other metrics to characterize 30CST task
performance for the supervised session and subsequent unsupervised period.

Figure 6. Raw triaxial accelerometer data (top) captured from an inertial sensor attached directly
to the skin of the right thigh while performing the 30CST were transformed into the
anatomically relevant reference frames (right) using the direction of gravity to align the z-axis
(CC component). The CC component of the signal was low-pass filtered (bottom) and stand and
sit events identified using the peak maximum and minimum values (denoted by circles). These
events were used to compute temporal characteristics of the task, such as the maximum sit-stand
time (max si-st time) shown as the time between the dotted and solid lines.

3.2.3 Performance metrics
Performance metrics extracted for the supervised session included the
mean, maximum and minimum si-st and st-si transition times across all repetitions
of one 30CST (Figure 2 illustrates an example of a maximum si-st transition time),
as well as the number of 30CST repetitions performed. Performance metrics
extracted for the unsupervised monitoring period included the average, maximum
and minimum number of 30CST repetitions performed over the monitoring
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period, and the average, minimum and maximum si-st and st-si times for each
30CST performed averaged across all tests performed.
3.2.4 Statistical analysis
Independent sample Student’s t-tests were used to evaluate differences
between fallers and non-fallers for all clinical outcome measures and
accelerometer-derived metrics. Effect size was evaluated where appropriate using
the Cohen’s d statistic (d). Supervised and averaged values for analogous
unsupervised metrics were also compared using paired sample Student’s t-tests to
evaluate how supervised performance relates to average unsupervised
performance over 48-hours. Variables characterized using Likert scales were not
normally distributed thus differences were evaluated using Wilcoxon Rank Sum
Tests.
Receiver operating characteristics (ROC) analysis was used to compare the
ability of gross measures of performance (i.e., number of repetitions) and temporal
metrics computed automatically from the thigh sensor to classify fall status. Cutoff
thresholds of fall risk for each metric were established by minimizing the value for
the Euclidian index [116]. Classifier performance was assessed using the area
under the curve (AUC), as well as classification accuracy, sensitivity, and
specificity for each threshold. The AUC provides a straightforward method for
ranking the performance metrics’ ability to distinguish between groups and
provides a quantifiable measure to compare between the supervised and
unsupervised conditions [70]. All statistical analyses were performed in SPSS
(SPSS Inc., Chicago, IL).
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3.3. Results
3.3.1 Supervised performance
Data for three participants were disregarded due to sensor technical
difficulties or non-compliance of unsupervised protocols. Fallers (n=21) and nonfallers (n=16) demonstrated statistically significant differences in age (p=0.009,
d=0.92), EDSS (p=0.002, d=1.10), ABC (p=0.006, d=0.99), and MFIS (p=0.008,
d=0.95) (Table 4). Performance metrics that were significantly different between
groups included the number of 30CST repetitions (p=0.01, d=0.88), average si-st
time (p=0.007, d=0.87), maximum si-st time (p=0.03, d=0.67), minimum si-st time
(p=0.01, d=0.82), average st-si time (p=0.01, d=0.88), maximum st-si time
(p=0.008, d=0.95) and minimum st-si time (p=0.02, d=0.79) (Table 4).

Table 4. Patient demographics and accelerometer derived performance metrics for study
participants for the supervised and unsupervised observation periods

Metric
Participant Characteristic
Age (yrs)
EDSS
MFIS
ABC
Supervised
30CST (# reps)
Avg sit-stand time (s)
Max sit-stand time (s)
Min sit-stand time (s)
Avg stand-sit time (s)
Max stand-sit time (s)
Min stand-sit time (s)
Unsupervised
#30CST Assessments performed
Avg 30CST (# reps)

Cohort
(n=37)

Non-Fallers
(n=21)

Fallers
(n=21)

p

d

50.6 (12.3)
2.7 (1.3)
34.2 (18.1)
81.4 (16.9)

44.5 (12.8)
2.0 (0.8)
24.9 (17.4)
90.4 (10.6)

54.9 (10.1)
3.3 (1.4)
40.5 (15.9)
75.3 (17.8)

0.009
0.002
0.008
0.006

0.92
1.10
0.95
0.99

12.1 (3.0)
1.3 (0.3)
1.7 (0.6)
1.1 (0.3)
1.3 (0.3)
1.5 (0.4)
1.2 (0.3)

13.5 (3.0)
1.1 (0.2)
1.4 (0.4)
1.0 (0.2)
1.2 (0.2)
1.3 (0.2)
1.0 (0.2)

11.1 (2.6)
1.4 (0.4)
1.8 (0.6)
1.2 (0.4)
1.4 (0.3)
1.6 (0.4)
1.3 (0.3)

0.01
0.007
0.03
0.01
0.01
0.008
0.02

0.88
0.87
0.67
0.82
0.88
0.95
0.79

12.0 (3.4)
12.9 (3.7)

11.5 (4.1)
14.3 (3.0)

12.3 (3.0)
11.7 (3.1)

0.46
0.02

0.84
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Self-report 30CST error (# reps)
Max 30CST (# reps)
Min 30CST (# reps)
Min sit-stand time (s)
Avg stand-sit time (s)
Max stand-sit time (s)
Min stand-sit time (s)
Balance Confidence (median)
Fatigue (median)

0.9 (1.4)
14.8 (3.9)
10.1 (3.2)
1.1 (0.3)
1.2 (0.4)
1.4 (0.5)
1.1 (0.3)
1
1

1.2 (1.4)
16.8 (2.9)
11.7 (4.0)
0.9 (0.2)
1.0 (0.2)
1.1 (0.4)
0.9 (0.2)
1
1

0.80 (1.3)
13.5 (4.0)
9.0 (2.1)
1.1 (0.3)
1.3 (0.4)
1.5 (0.4)
1.2 (0.3)
2
2

0.006
0.01
0.01
0.03
0.002
0.003
0.01
0.008
0.02

0.27
0.92
0.87
0.75
0.98
1.06
0.86
-

P-values were based on independent sample Student’s T-tests comparing fallers to nonfallers and effect sizes were evaluated using Cohen’s d. Clinical measures included the
Expanded Disability Status Scale (EDSS), Modified Fatigue Impact Scale (MFIS), and Activity
Balance Confidence scale (ABC). 30-Second Chair Stand (30CST) performance was measured
by the number of repetitions (reps).

3.3.2 Unsupervised performance
Participants performed an average of 12.0 ± 3.4 individual 30CST
assessments over the 48-hour monitoring period, which was not different between
groups (p=0.46, Table 4). Non-fallers averaged more repetitions across all
unsupervised 30CST assessments (p=0.02, d=0.84) and their self-reported 30CST
performance deviated more than that of fallers compared to the automated
algorithm (p=0.006, d=0.27); however, range of 30CST repetitions was not different
between the groups (p=0.55) (Table 4). Additionally, there were statistically
significant differences for the following performance metrics: minimum number
of repetitions performed for a single 30CST (p=0.01, d=0.87), maximum number of
repetitions performed for a single 30CST (p=0.01, d=0.92), minimum si-st time
(p=0.03, d=0.75), average st-si time (p=0.002, d=0.98), maximum st-si time (p=0.003,
d=1.06) and minimum st-si time (p=0.01, d=0.86) (Table 4).
Overall, the cohort reported confidence in their balance during the
unsupervised period as 83% of all responses were rated as “confident” or “very
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confident”, though fallers were more likely to experience decreased balance
confidence (p=0.008, Figure 7, Table 4). Similarly, fatigue was generally rated low
(i.e., “never” or “rarely”) for 75% of the responses across the group but was higher
for fallers (p=0.02, Figure 7 Table 4).
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Figure 7. Frequency distribution for bi-hourly self-reported ratings of balance confidence and
fatigue for the unsupervised monitoring period for fallers (F) and non-fallers (NF). Balance
confidence was evaluated with the question “In the last 2 hours, how confident were you that
you would not fall?” and the response choices were: “(1) Very Confident, (2) Confident, (3)
Neutral, (4) Not Confident or (5) Very Not Confident.” Fatigue was evaluated with the question
“In the last 2 hours, how often has fatigue prevented the completion of tasks that require
physical effort?” and the response choices were: “(1) Never, (2) Rarely, (3) Sometimes, (4) Often
or (5) Always.”

3.3.3 Comparison of supervised and unsupervised performance
As a group, unsupervised 30CST performance (number of repetitions
averaged for all unsupervised assessments) was significantly different from
supervised performance (p=0.03, d=0.37), as was minimum si-st time (p=0.03,
d=0.37), average st-si time (p=0.004, d=0.51) and minimum st-si time (p=0.002,
d=0.54) (Table 5). When grouped by fall status, fallers demonstrated no differences
between supervised and unsupervised performance for any performance metric
(Table 5). However, non-fallers on average performed more repetitions during
free-living (p=0.02, d=0.65) with a decreased average st-si time (p=0.002, d=1.0)
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and a decreased minimum stand-sit time (0.002, d=1.0) (Table 5). Figure 8
illustrates variable 30CST performance for a participant classified as a non-faller
during the supervised laboratory session (repetitions = 13, Figure 8a), and two
unsupervised 30CST (repetitions = 14, Figure 8b; repetitions = 6, Figure 8c).
Table 5. Comparison of supervised and unsupervised (averaged for all 30CST assessments
performed during the unsupervised period) 30CST gross performance and accelerometer
derived performance metrics for the cohort, non-fallers and fallers.

Performance Metric

Supervised

Average
Unsupervised

p

d

Cohort
30CST (# reps)
Avg sit-stand time (s)
Max sit-stand time (s)
Min sit-stand time (s)
Avg stand-sit time (s)
Max stand-sit time (s)
Min stand-sit time (s)

12.1 (3.0)
1.3 (0.3)
1.6 (0.6)
1.1 (0.3)
1.3 (0.3)
1.5 (0.3)
1.2 (0.3)

12.9 (3.2)
1.2 (0.4)
1.7 (0.8)
1.1 (0.3)
1.2 (0.3)
1.4 (0.4)
1.1 (0.3)

0.03
0.03
0.81
0.03
0.004
0.11
0.002

0.37
0.36
0.37
0.51
0.54

Non-Fallers
30CST (# reps)
Avg sit-stand time (s)
Max sit-stand time (s)
Min sit-stand time (s)
Avg stand-sit time (s)
Max stand-sit time (s)
Min stand-sit time (s)

13.5 (3.0)
1.1 (0.2)
1.4 (0.4)
1.0 (0.2)
1.2 (0.2)
1.3 (0.2)
1.0 (0.2)

14.5 (2.9)
1.1 (0.2)
1.5 (0.9)
0.9 (0.2)
1.0 (0.2)
1.2 (0.2)
0.9 (0.2)

0.02
0.14
0.91
0.18
0.002
0.12
0.002

0.65
1.0
1.0

Fallers
30CST (# reps)
Avg sit-stand time (s)
Max sit-stand time (s)
Min sit-stand time (s)
Avg stand-sit time (s)
Max stand-sit time (s)
Min stand-sit time (s)

11.1 (2.6)
1.4 (0.4)
1.8 (0.6)
1.2 (0.4)
1.4 (0.3)
1.6 (0.4)
1.3 (0.3)

11.7 (3.0)
1.3 (0.3)
1.8 (0.6)
1.1 (0.3)
1.3 (0.4)
1.5 (0.4)
1.2 (0.3)

0.23
0.13
0.75
0.10
0.11
0.43
0.07

-

30-second chair stand test (30CST), repetitions (reps). P-values were based on
paired sample Student’s T-tests comparing analogous metrics for the
supervised and unsupervised (averaged) 30CSTs and effect sizes were
evaluated using Cohen’s d.

40

Figure 8. Comparison of supervised and unsupervised 30CST performance for a single
participant (female NF, age: 39, EDSS: 1.5, MFIS: 44, ABC: 99.4). Standing and sitting events are
denoted by circles (maximum and minimum values, respectively).

3.3.4 ROC analysis and falls classification
Classification accuracy for supervised 30CST performance was 67.6% with
an optimal cutoff score of 13 repetitions and associated ROC AUC of 0.73 (Table
6). Maximum st-si time increased classification accuracy to 75.7% compared to
counting 30CST repetitions (max st-si time cutoff = 1.24, AUC = 0.76, Table 6).
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Average unsupervised 30CST performance improved AUC (0.76) and accuracy
(75.7%) compared to supervised 30CST with a cutoff of 13.9 average repetitions.
Fall classification accuracy and AUC were maximized for this cohort by
considering the maximum number of repetitions performed across all free-living
30CSTs with a cutoff threshold of 17 repetitions (AUC = 0.79, accuracy = 78.4%,
Table 6).

Table 6. Classification performance for ROC analysis comparing 30CST gross measures of
performance and accelerometer derived features.
Feature

Recommended
Cutoff

AUC

Accuracy
(%)

Sensitivity
(%)

Specificity
(%)

67.6
67.6
73.0
64.9
70.3
70.3
75.7

60.0
77.3
68.2
54.5
72.7
68.2
86.4

72.7
60.0
80.0
80.0
66.7
73.3
60.0

75.7
78.4
70.2
67.6
75.7
78.4
73.0
73.0
73.0

60.0
73.3
86.7
63.6
86.4
72.7
68.2
81.8
77.3

86.4
90.9
59.1
73.3
60.0
86.7
80.0
66.7
66.7

Supervised
30CST (# reps)
Avg sit-stand time (s)
Min sit-stand time (s)
Max sit-stand time (s)
Avg stand-sit time (s)
Min stand-sit time (s)
Max stand-sit time (s)

13
1.14
1.07
1.6
1.21
1.13
1.24

Avg 30CST (# reps)
Max 30CST (# reps)
Min 30CST (# reps)
Avg sit-stand time (s)
Min sit-stand time (s)
Max sit-stand time (s)
Avg stand-sit time (s)
Min stand-sit time (s)
Max stand-sit time (s)

13.9
17
10
1.16
0.92
1.48
1.13
0.97
1.25

0.73 (0.57, 0.89)
0.73 (0.56, 0.89)
0.73 (0.57, 0.89)
0.71 (0.54, 0.88)
0.75 (0.59, 0.91)
0.74 (0.55, 0.88)
0.76 (0.60, 0.91)
Unsupervised
0.76 (0.61, 0.92)
0.79 (0.64, 0.94)
0.77 (0.61, 0.94)
0.73 (0.57, 0.90)
0.74 (0.58, 0.91)
0.78 (0.61, 0.94)
0.79 (0.64, 0.93)
0.77 (0.61, 0.92)
0.79 (0.64, 0.94)

30CST: 30-second chair stand test, reps: repetitions; ROC AUC values include 95% confidence intervals.

3.4. Discussion
To our knowledge this is the first study to observe and assess free-living
30CST performance using metrics derived from a single wearable sensor in PwMS
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and compare to supervised performance. AUC analysis for this relatively low
disability cohort suggested that a performance threshold of 13 repetitions for a
supervised clinic assessment may optimize the detection of PwMS at risk for falls.
Combined with other clinical tests and measures, this information could be
utilized to further investigate fall risk and refer to supportive therapies to preempt
a future fall from occurring. Yet similar to other studies in PwMS these data
underscore how performance at a supervised clinic visit may not reflect the
average performance during free-living conditions, and that those features
characterizing the bounds of performance, such as the maximum number of 30CST
repetitions performed over a short free-living period, may differentiate between
groups with larger effects and higher falls classification accuracy (Tables 4 and 6)
[70]. Our data elucidate the potential advantage of augmenting clinical visits with
unsupervised monitoring via wearable sensors to gain a broader perspective of
patient function, symptom fluctuation and fall risk during free-living conditions.
The benefits of short duration free-living assessment of functional mobility
may not be restricted to potential fallers as differences in performance between the
laboratory and free-living environments were driven primarily by non-fallers
(Table 5). This may be consistent with previous findings that PwMS who
experience more fatigue related disruption in their daily life consciously limit their
activities which leads to decreased variability of functional task performance and
physical activity [117]. Thus brief periods of unsupervised monitoring using
wearable sensors could be useful to target patients that might benefit from tailored
activity pacing interventions to optimize their overall total physical activity
without exacerbating fatigue [118]. For example, Figure 8 illustrates the
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performance variability for a participant classified as a non-faller during
supervised (Figure 8a) and unsupervised (Figure 8b and Figure 8c) timepoints.
While this individual performed at the recommended cutoff threshold during
supervised (Figure 8a) and some unsupervised (Figure 8b) trials, we observed a
notable divergence in performance for several 30CST performance metrics (Figure
8c) such as unsupervised 30CST performance below the recommended
(minimum) cutoff threshold of 10 repetitions (Table 6) and (averaged) maximum
stand-sit time of 1.6 seconds (not shown in Figure 4) greater than recommended
threshold of 1.25 seconds (Table 6) despite no change in their self-reported fatigue
and balance confidence.
The st-si transition phase may be an informative biomarker for detecting
fall risk, which is consistent with previous findings [65] albeit with a different
interpretation. Our inclusion of maximal si-st and st-si time features captured
intra-transition variability within a single 30CST, and the associated accelerometer
signal (see Figure 7 bottom panel and Figure 8c) may suggest that the underlying
cause of an increased st-si time reflected instabilities when a participant paused
mid-transition to maintain their balance. Additionally, increased st-si time
differentiated between the groups with strong effects in both the supervised and
unsupervised environments (Table 4).
The results here indicate that establishing statistically rigorous thresholds
for interpreting performance change over time in neurological populations might
be complicated by symptom fluctuation. Previous studies have recommended
using a test/re-test paradigm to compute the minimum detectable change (MDC)
or minimally clinically important difference (MCID) to evaluate the effectiveness
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of therapeutic interventions [46,119,120]. Data supporting clinically significant
changes for the 30CST are limited, with one group suggesting a MCID of three for
people with hip osteoarthritis [113]. We found an average range of 30CST
performance during the unsupervised period of 4.7±3.3 repetitions for the cohort
with 90% of participants fluctuating by at least three repetitions over the
unsupervised monitoring period. Thus, the clinical community may need to
reconsider how to determine statistically meaningful changes in patient
populations where symptoms fluctuate, particularly when utilizing objective
functional assessments to study intervention efficacy.
Despite our relatively small sample size and short duration of unsupervised
monitoring we elucidate how functional mobility during daily life may vary
substantially from that observed during supervised clinical visits. Our findings are
consistent with other studies that demonstrate the value of short unsupervised
monitoring periods for quantifying variability of performance throughout the day
[70,121]. However, there were limitations to characterizing fall risk during freeliving scenarios using this task. Our inability to confirm participants complied
with 30CST instructions could have led to discrepancies in chair height, naturally
leading to performance differences not strictly related to capacity or symptom
fluctuation. Additionally, while the clinical community has adopted standardized
functional tests to provide insight into mobility impairment, the relatively low
AUC and accuracy of this gross measure of performance (Table 6) suggest it may
be suboptimal for identifying differences in relatively low-disability neurological
cohorts. Future research directions should include exploring new biomarkers of
performance from individual sit-stand transitions and other functional tasks
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during free-living from a more diverse cohort to further improve the methodology
for identifying fall risk.
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Chapter 4: The Sit-to-Stand Transition as a Biomarker for Impairment is
Context Dependent: Comparison of Instrumented 30-Second Chair Stand Test
and Daily Life Transitions in Multiple Sclerosis

4.1. Introduction
Multiple

sclerosis

is

an

immune-mediated

disease

that

causes

inflammation, demyelination and neurodegeneration of the central nervous
system leading to compromised nerve signaling between the brain and body. The
disruption in signal transmission of the sensorimotor systems lead to a high
incidence of balance deficits, mobility problems, and elevated fall risk in people
with multiple sclerosis (PwMS) [33,104] across all levels of disability [103]. As
such, approximately 50% of PwMS will fall in a given three-month period [23] and
it has been shown that pyramidal and sensory impairment are greater in fallers
[122]. While balance is comprised of an integrated, multifactorial system inclusive
of both pyramidal and sensory components, they contribute to functional mobility
differently. Proprioceptive deficits of lower extremities occur in two-thirds of
PwMS and are associated with poor awareness of where the limbs are in space
[11,123,124] whereas pyramidal impairments are associated with spasticity and
lower extremity strength deficits reflected in decrements of functional and
walking capacity [8,125].
While there is ample evidence that interventions across a spectrum of
disability levels lead to improvements in balance, physical functioning and
decreased fall risk [99,126,127], establishing specific contribution to impairment
remains a challenge in the clinic as clinicians are currently limited by rudimentary
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tools and time to perform complex assessments during routine exams. Thus,
clinicians continue to rely on patient reported outcomes and standardized
functional assessments to guide patient care [39–42]; however, a growing body of
evidence is demonstrating the utility of wearables for longitudinal monitoring,
personalized intervention and preventative care [128]. As wearable sensors are
becoming ubiquitous for biomechanical and gait analysis there is ample evidence
that instrumented functional assessments improve the discriminative ability to
detect group differences and could provide useful objective measures of
performance during clinic visits [54,64,65,111]. However studies comparing
laboratory to daily life performance are converging on the consensus that
measurements from supervised settings may not directly translate to mobility
impairment during daily life [67,67–69,121,129]. Many recent studies have focused
on performance differences in the laboratory and free living contexts to
discriminate between neurological impairment and healthy controls during gait
[67–70], turns [121] and sit-stand transitions [75]. While these differences are
interesting, clinicians may benefit from a deeper understanding of the underlying
mechanisms for these differences and information from varied contexts could be
useful for deploying personalized interventions to target specific impairments.
Thus, we posit that there may be benefits to both supervised and
unsupervised assessments. To our knowledge no previous study has directly
compared supervised and unsupervised performance during a structured task to
a similar task performed during daily life to investigate specific contributions to
impairment and fall risk. In this study we identified sit-stand and stand-sit
transitions performed during daily life during two days of unsupervised
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monitoring and compared performance metrics derived from wearable sensors to
those from a supervised and unsupervised 30-second chair stand test (30CST).
Specifically, we sought to understand how performance in each context may
inform fall risk, and sensory and pyramidal impairment.

4.2. Methods
4.2.1 Participants and supervised data collection
Forty PwMS (inclusion: no major health conditions affecting balance other
than MS, no acute exacerbations within the previous 3-months, ambulatory
without assistive devices) were recruited from the University of Vermont Medical
Center Multiple Sclerosis Center and dichotomized by fall status. Fallers were
identified with a questionnaire asking if they had sustained a fall in the previous
6-months where a fall was characterized “as an event where you unintentionally
came to rest on the ground or a lower level”.
Participants were instrumented with two inertial sensors (Biostamp, MC10,
Inc., Lexington, MA) adhered directly to the skin; one sensor was located on the
midpoint of the thigh approximately aligned with the femur and the second sensor
was located on the chest located approximately one inch distal to the sternal notch.
The sensors recorded triaxial accelerometer data (sampling rate 250 Hz, ±16 g)
while participants performed one trial of the 30CST in which they completed sitto-stand transitions from a 17-inch chair as quickly and safely as they felt
comfortable with arms crossed over their chest. Participants completed
standardized outcome measures related to fall risk [79,80] including the Modified
Fatigue Impact Scale (MFIS) [77] and the Activities-Specific Balance Confidence
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scale (ABC) [78].

Participant disability was quantified with the expanded

disability status scale (EDSS) [130] administered by a neurologist. The EDSS
pyramidal and sensory subscores were used to dichotomize the group into
additional classification schemas to investigate pyramidal and sensory
impairment [131,132]. Participants were divided into those without pyramidal
impairment (rated at 0 or +1) and those with manifest clinical disability (rated
above +1). Similarly, participants that were rated at 0 normal or +1 in the sensory
subscore were classified as having no sensory impairment and any participants
that received a score above +1 were classified as having sensory involvement with
manifest clinical disability. The experimental protocol was approved by the
University of Vermont IRB and all participants provided informed consent.
4.2.2 Unsupervised data collection
Participants completed approximately two days of daily life unsupervised
monitoring immediately following the supervised session. Prior to leaving the
laboratory new sensors were placed on the right thigh and chest in the same
location and the participants were provided with a smartphone and oriented to an
application that interfaced with the MC10 sensors (i.e., MC10 Link App) to
facilitate unsupervised data collection. The sensors are waterproof thus
participants wore the sensors continuously during the unsupervised period and
all data were stored in the sensors’ local memory. Accelerometer data were
uploaded to a secure MC10 cloud-based database once the sensors were returned
via mail, and the data were downloaded to a local server for processing. During
unsupervised monitoring participants were asked to complete bi-hourly 30CSTs
(timeframe 07:00 to 21:00) and an alarm was enabled on the smartphone at the
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requested task completion times to facilitate adherence. Study personnel provided
a handout with instructions and reviewed the 30CST technique which included
the type of chair to use and how the chair should be positioned against a stable
surface for safety.
4.2.3 Data processing for 30CST data
The raw accelerometer data for all 30CSTs (supervised and unsupervised)
were processed using a fully automated Matlab algorithm (Mathworks, Natick
MA). The algorithm used only the thigh accelerometer signal to delineate the sitto-stand (si-st) and stand-to-sit (st-si) phases of each 30CST repetition and has been
previously detailed [111,129] (Figure 5). Briefly, the raw accelerometer data were
projected onto participant-specific thigh reference frames using data from the
static standing trial. The new reference frame was approximately aligned with the
anterior-posterior (AP), medial-lateral (ML) and cranial-caudal (CC) directions
(Figure 5, right) using the known thigh sensor location and the direction of gravity.
The 30CST data were low pass filtered using a 3rd order Butterworth IIR filter with
a cutoff frequency equal to the dominant frequency observed during the 30CST.
Sit and stand events were then identified as the minimum and maximum values,
respectively, in the cranial-caudal component (Figure 5, bottom).
4.2.3.1 Performance metrics: supervised 30CST
Performance metrics extracted for the supervised session included
temporal and acceleration features from each of the triaxial acceleration
components. Sit and stand events were used to compute si-st and st-si duration
times for each transition then temporal features were extracted from the CC
component of the thigh acceleration which included the average, median,
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maximum, and minimum si-st and st-si transition times across all repetitions of
one 30CST as well as the number of 30CST repetitions performed. Triaxial (AP, CC
and ML) peak and minimum thigh and chest accelerations were extracted within
the first and second half of each 30CST transition (Figure 5) from raw
accelerometer signals bandpass filtered using a 3rd-order Butterworth IIR filter
with cutoff frequencies of 5 and 20 Hz. These cutoffs were selected to limit signal
content to a physiologically relevant range while also removing the effects of
changes in sensor orientation. The average and median of the peak and minimum
accelerations as well as the 95th percentile and 5th percentile acceleration values
across all repetitions of each 30CST in the first and second halves of the sit-stand
and stand-sit transitions were computed and used as performance metrics for
analysis. Details of this approach are provided in [111].
4.2.3.2 Performance metrics: unsupervised 30CST
Participants had to complete a minimum of four 30CST assessments during
the unsupervised period for the purposes of performing statistical analysis, which
represented the 5th percentile of the range of all 30CST assessments performed for
all participants. The raw accelerometer data for each 30CST were processed using
the same algorithm as described for the supervised 30CST to delineate each 30CST
assessment into si-st and st-si components for analysis. The minimum, maximum
and average si-st and st-si times were computed for each 30CST. Triaxial (AP, CC
and ML) peak and minimum thigh and chest accelerations were extracted within
the first and second half of each 30CST transition. The performance metrics were
found by evaluating the average and median values across all 30CSTs for each
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temporal (thigh) and accelerometer (thigh and chest) metric. The overall average
and median si-st and st-si times across all 30CST repetitions were also computed.
4.2.4 Data processing for daily life data
Figure 9 provides an overview of the novel approach and data processing
steps to identify sit-stand and stand-sit transitions during daily life. Activity bouts
were identified from chest and thigh wearable sensor data using a deep learning
approach that leverages a Long Short Term Memory (LSTM) architecture adapted
from [133]. This model was trained to identify walking, standing, sitting, lying,
and “other” (i.e., non-classified activities).

Specifically, the network was

composed of a LSTM layer with 215 hidden units and a 30% drop out layer,
followed by a BiLSTM Layer with 125 hidden units, a 40% drop out layer and
Adam optimization [134]. This classifier was developed using 58% data from
PwMS, 26% from healthy adults, and 16% from persons with Parkinson’s Disease
to provide a wide variety of example activities. Data labeled as walking, standing,
sitting, or lying came from prescribed activities from supervised (laboratory) data
collection sessions. Data labeled as “other” consisted of running, stair ascent, stair
descent and unidentifiable periods of activity. Ten-fold cross validation was
conducted on the training set consisting of 97,000 4-second observations
(1:1:1:1:0.85 walk:stand:sit:lie:other) yielding validation AUC of 0.99 for sitting.
Data from a given participant were not included in both training and held-out test
sets. Performance on a held-out test set consisting of 31,863 observations
(1:1:1:1:0.66 walk:stand:sit:lie:other) achieved 96.3% accuracy overall, providing
evidence that the classifier was appropriate for use on new datasets.
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The model was then leveraged to identify all sitting bouts completed by
participants during the 48-hour free-living period. All sitting bouts greater than
30-seconds identified by the classifier were extracted for further analysis as
potential sit-stand or stand-sit transitions. Nine seconds of raw data were
extracted from either side of the relevant timestamp to create windows 18-seconds
in length that encompassed either the beginning or ending timestamps of each
sitting bout to examine each window for a potential stand-sit or sit-stand
transition, respectively. The raw accelerometer data were then processed using a
fully automated Matlab algorithm (Mathworks, Natick MA). The CC-component
of the raw acceleration was low-pass filtered (LPF) and passed through a series of
validation steps which included the LPF signal passing through 0.5 g and greater
than 0.5 g of total range for the window of data (see Figure 9). The sit and stand
events were identified as the minimum and peak values, respectively, closest
temporally to the transition point. Approximately one-third of the participants’
data were visually inspected to ensure the automated algorithm was correctly
discarding windows that did not contain a transition.
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Figure 9. Overview of daily life sit-stand (si-st) and stand-sit (st-si) transition data processing. The
example shown illustrates the pipeline for st-si transitions but the methodology was the same for
si-st transitions.

4.2.4.1 Performance metrics: daily life transitions
The minimum, maximum and average si-st and st-si times were computed
for each across all sit-stand and stand-sit transitions identified during daily life
(Figure 2). Triaxial (AP, CC and ML) peak and minimum thigh and chest
accelerations were extracted within the first and second half of each sit-stand and
stand-sit transition similar to the 30CST data. The average and median of the peak
and minimum accelerations as well as the 95th percentile and 5th percentile
acceleration values across all sit-stand and stand-sit transitions during daily in the
first and second halves of the sit-stand and stand-sit transitions were computed
and used as the performance metrics for the analysis.
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4.2.5 Statistical analysis
Independent sample Student’s t-tests and Wilcoxon Rank Sum Tests (for
non-normal variables determined via Kolmogorov-Smirnov test) were used to
evaluate differences between fallers and non-fallers, non-pyramidal and
pyramidal impairment and sensory and non-sensory impairment for all clinical
outcome measures and accelerometer-derived thigh and chest performance
metrics with a threshold of p<0.05. Then for all accelerometer-derived metrics
demonstrating statistically significant differences between groups, receiver
operating characteristics (ROC) analysis was used to classify fall risk status
(high/low), no pyramidal vs pyramidal impairment (NPI/PI) and no sensory vs
sensory impairment (NSI/SI). The area under the receiver operator characteristic
(ROC) curve (AUC) was used to quantify each performance metrics’ ability to
distinguish between groups and enables a quantitative comparison across all three
conditions (supervised 30CST, unsupervised 30CST, daily life) [28]. We ranked all
features from highest to lowest AUC and reported those that achieved AUC > 0.75
for discriminating high and low fall risk, pyramidal impairment, and sensory
impairment. Effect size was also evaluated where appropriate using the Cohen’s
d statistic (d). All statistical analyses were performed in SPSS (SPSS Inc., Chicago,
IL).

4.3. Results
4.3.1 Group characteristics
Table 7 summarizes the demographics for the participants. Data for three
participants were disregarded due to sensor technical difficulties or non56

compliance of unsupervised protocols; of the remaining 37 participants there were
21 fallers, 14 participants with pyramidal impairment and 24 with sensory
impairment. Across all groups there were no differences in total hours of
unsupervised monitoring, total number of 30CST assessments performed during
the unsupervised monitoring period, or total number of daily life sit-stand
transitions identified during the two days of unsupervised monitoring. Fallers
were older and more impaired in their EDSS and ABC scores compared to nonfallers. Participants with pyramidal impairment were older, more impaired in
EDSS and ABC scores and self-reported higher levels of fatigue. Only EDSS and
MFIS scores were different for those with sensory impairment. Adherence to the
unsupervised monitoring were similar between all group pairings in terms of
number of hours of monitoring (cohort: average = 44.8 ± 5.2 hours), number of
30CST assessments performed during the unsupervised monitoring period
(cohort: average = 12.2 ± 3.0 assessments, range = 4 to 16), and number of daily life
transitions detected during the unsupervised monitoring period (cohort: average
= 59.2 ± 17.3 hours).

Table 7. Participant demographics and adherence during unsupervised monitoring.
Demographics

Unsupervised Monitoring

Group

Age
(yrs)

EDSS

ABC

MFIS

30CST
assessments
(#)

Hours of
monitoring
(hrs)

Daily life
transitions
(#)

Cohort
(n=37)

50.6±12.3

2.6±1.4

81.3±17.7

32.8±18.8

12.2±3.0

44.8±5.2

59.2±17.3

44.7±12.4

2.0±1.0

88.9±12.5

26.9±18.8

11.9±3.5

45.4±33

59.6±20.4

55.2±10.3

3.1±1.5

75.5±19.1

37.3±18.0

12.5±2.6

44.3±6.4

58.9±15.0

NF
(n=16)
F
(n=16)
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p
MPI
(n=23)
PI
(n=14)
p
MSI
(n=13)
SI
(n=24)
p

0.008

0.01

0.02

0.10

0.58

0.54

0.90

46.6±12.4

2.0±1.0

89.9±11.4

27.3±17.5

11.8±3.4

43.9±6.5

59.5±20.6

57.3±8.9

3.6±1.4

67.1±17.2

41.9±18.0

12.9±1.6

46.1±0.3

58.5±10.4

0.008

0.0004

<0.0001

0.02

0.28

0.22

0.87

45.8±12.9

1.9±1.5

87.6±17.4

24.1±18.6

13.5±1.2

46.2±0.3

61.5±16.9

53.3±11.3

3.0±1.1

77.9±17.2

37.5±17.6

11.7±3.4

44.0±6.4

57.9±17.7

0.07

0.01

0.11

0.04

0.11

0.23

0.55

NF: non-faller, F: faller, NPI: no pyramidal impairment, PI: pyramidal impairment, NSI: no
sensory impairment, SI: sensory impairment, EDSS: Expanded Disability Status Scale, MFIS:
Modified Fatigue Impact Scale, ABC: Activity Balance Confidence, 30CST: 30-second chair stand
test. P-values were based on independent sample Student’s T-tests comparing groups.

4.3.2 Discriminating fall status
A total of thirteen features (supervised 30CST = 4, unsupervised 30CST = 6,
daily life = 3) including chest and thigh derived performance features (chest = 4,
thigh = 9) discriminated fall status with AUC>0.75 (Figure 10) and p<0.05 (Table
8). 30CST performance achieved statistically significant difference but not AUC >
0.75 (Table 8). The feature that best discriminated fallers and non-fallers was the
average sit-stand time computed from the thigh sensor across all daily life sit-tostand transitions (Avg Si-St Time, AUC=0.854, p<0.001, d=1.285), Figure 10, Table
8).
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Faller vs Non-Faller

Med of Max Si-St Time (s)
Avg of Min CC Accel Si-St (2) (g)
Med of Min CC Accel Si-St (2) (g)
Avg of Max Si-St Time (s)
Med of Avg Si-St Time (s)
Med of Min ML Accel St-Si (2) (g)

0.786
0.767
0.767
0.765
0.759
0.757

Unsupervised
30CST

0.793
0.783
0.763
0.750

Supervised
30CST

Avg of Min CC Accel Si-St (2) (g)
Med of Min CC Accel Si-St (2) (g)
5th Percentile CC Accel Si-St (2) (g)
95th Percentile Si-St Time (s)

Daily
Life

0.854
0.786
0.753

Avg Si-St Time (s)
Med Si-St Time (s)
95th Percentile Si-St Time (s)

Pyramidal vs No Pyramidal Impairment

Avg St-Si Time (s)
Med St-Si Time (s)

0.822
0.815
0.801
0.794
0.787
0.780
0.779
0.773
0.755
0.776
0.761

Daily
Life

Med Si-St Time (s)
Med of Min Si-St Time (s)
Med of Avg St-Si Time (s)
Med of Avg Si-St Time (s)
Avg St-Si Time (s)
Avg of Min St-Si Time (s)
Avg 30CST Performance (# reps)
Med of Max St-Si Time (s)
Avg Si-St Time (s)

0.846
0.829
0.825
0.818
0.815
0.808
0.804
0.801
0.801
0.787
0.762

Unsupervised
30CST

Percentile CC Accel St-Si (1) (g)
Avg Si-St Time (s)
30CST Performance (# reps)
Min St-Si Time (s)
Med Si-St Time (s)
Avg of Min CC Accel St-Si (1) (g)
Avg St-Si Time (s)
Min Si-St Time (s)
Med St-Si Time (s)
Max Si-St Time (s)
Max St-Si Time (s)

Supervised
30CST

5th

Sensory vs No Sensory Impairment
0.807
0.792
0.788
0.784
0.773
Thigh Derived Metric

0.0

0.2

0.4

Supervised
30CST

Med of Min ML Accel St-Si (1) (g)
Avg of Min AP Accel St-Si (1) (g)
Avg of Min ML Accel St-Si (1) (g)
Avg of Min CC Accel St-Si (1) (g)
5th Percentile AP Accel St-Si (1) (g)

Chest Derived Metric

0.6

0.8

1.0

Area Under the ROC Curve (AUC)

Figure 10. Comparison of performance metrics with AUC > 0.75 for supervised 30CST,
unsupervised 30CST and daily life transitions for three groups of classifiers: fallers vs nonfallers, pyramidal vs no pyramidal impairment and sensory vs no sensory impairment.
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Table 8. Comparison of performance metrics derived from supervised 30CSTs, unsupervised
30CSTs and daily life grouped by classifier.
p

d

-0.03±0.01
-0.03±0.01
-0.11±0.06
1.74±0.52
10.9±2.4

0.009
0.006
0.038
0.008
0.026

1.08
1.13
0.83
0.91
0.79

1.12±0.30
-0.06±0.02

1.81±0.91
-0.04±0.02

0.018
0.014

0.86
0.89

Median of (chest) min CC accel si-st (2) (g)
Avg of max si-st time (s)
Median of avg si-st time (s)
Median of (thigh) min ML accel st-si (1) (g)

-0.06±0.02
1.30±0.37
1.04±0.19
0.14±0.08

-0.04±0.02
1.93±0.85
1.33±0.43
0.083±0.03

0.008
0.014
0.029
0.004

0.97
0.89
0.79
1.06

Avg si-st time (s)
Median si-st time (s)
Max si-st time (s)

2.87±0.10
2.80±0.12
3.86±0.31

3.04±0.15
2.94±0.15
4.10±0.19

<0.001
0.004
0.008

1.29
1.01
0.94

NPI (n=23)

PI (n=14)

5th percentile (chest) CC accel st-si (1) (g)
Avg si-st time (s)
30CST performance (# reps)
Min st-si time (s)
Median si-st time (s)
Avg of (chest) min CC accel st-si (1) (g)
Avg st-si time (s)
Min si-st time (s)
Median st-si time(s)
Max si-st time (s)
Max st-si time (s)

-0.14±0.08
1.12±0.22
13.0±2.8
1.08±0.23
1.17±0.24
-0.08±0.04
1.20±0.26
1.03±0.20
1.20±0.26
1.36±0.27
1.34±0.32

-0.09±0.05
1.42±0.36
10.0±1.9
1.30±0.33
1.41±0.36
-0.05±0.02
1.423±0.32
1.24±0.36
1.42±0.30
1.75±0.52
1.58±0.35

0.029
0.019
0.002
0.031
0.031
0.040
0.030
0.048
0.032
0.008
0.040

0.77
0.81
1.18
0.77
0.77
0.73
0.77
0.70
0.76
0.91
0.73

Median si-st time (s)

1.04±0.21

1.38±0.40

0.013

1.13

Median of min si-st time (s)
Median of avg st-si time (s)

0.94±0.20
1.08±0.24

1.23±0.35
1.39±0.36

0.004
0.004

1.08
1.07

Median of avg si-st Time (s)
Avg st-si time (s)

1.07±0.24
1.12±0.32

1.42±0.46
1.41±0.40

0.018
0.022

1.01
0.84

Avg of min st-si time (s)
Avg 30CST performance (# reps)

0.99±0.27
14.00±3.2

1.26±0.35
11.0±2.4

0.017
0.060

0.88
1.01

Median of max st-si time (s)

1.20±0.27

1.53±0.40

0.006

1.03

Avg si-st Time (s)

1.12±0.27

1.44±0.45

0.015

0.89

Avg ± SD

Avg ± SD

Falls: F vs NF

NF (n=16)

F (n=21)

Avg of (chest) min CC accel si-st (2) (g)
Median of (chest) min CC accel si-st (2) (g)
5th percentile CC accel si-st (2) (g)
Max si-st time (s)
30CST performance (# reps)

-0.06±0.04
-0.05±0.03
-0.29±0.31
1.36±0.27
13.1±3.1

Median of max si-st time (s)
Avg of (chest) min CC accel si-st (2) (g)

Daily Life

Unsupervised
30CST

Supervised
30CST

Performance Metric

Unsupervised
30CST

Supervised
30CST

Pyramidal: NPI vs PI

60

Daily
Life

Avg st-si time (s)
Median st-si time (s)

2.71±0.20
2.66±0.23

2.90±0.16
2.84±0.17

0.005
0.018

1.02
0.84

NSI (n=11)

SI (n=24)

Median of (chest) min ML accel st-si (1) (g)

-0.038±0.013

-0.026 ±0.008

0.002

1.23

Avg of (chest) min AP accel st-si (1) (g)

-0.056±0.029

-0.035 ±0.012

0.005

1.10

Avg of (chest) min ML accel st-si (1) (g)

-0.041±0.015

-0.029 ±0.009

0.005

1.09

Avg of (chest) min CC accel st-si (1) (g)

-0.085±0.041

-0.054 ±0.023

0.007

1.05

5th percentile (chest) AP accel si-st (1) (g)

-0.092±0.052

-0.056 ±0.022

0.006

1.06

Supervised
30CST

Sensory: NSI vs SI

F: fallers, NF: non-fallers, NPI: minimal pyramidal impairment, PI: pyramidal impairment, NSI:
minimal sensory impairment, SI: sensory impairment CC: cranial-caudal, ML: medial-lateral,
AP: anterior-posterior, 30CST: 30-second chair stand test, reps: repetitions, si-st: sit-to-stand, stsi: stand-to-sit. P-values represent group comparisons based on independent sample Student’s
T-tests and effect sizes were evaluated using Cohen’s d.

4.3.3 Discriminating pyramidal impairment
A total of 22 features (supervised 30CST = 11, unsupervised 30CST = 9,
daily life = 2) discriminated between participants with and without pyramidal
impairment with AUC > 0.75 (Figure 10) and p<0.05 (Table 8). The three features
that best discriminated pyramidal impairment were all features from the
supervised 30CST. Specifically, the most discriminative feature was the 5th
percentile of chest caudal-cranial (CC) acceleration during the first half of the st-si
phase (5th percentile CC accel st-si (1), AUC=0.846, p=0.29, d=0.773), followed by
the average si-st time (AUC=0.829, p=0.019, d=0.809) and 30CST performance
(AUC=0.825, p=0.002, d=1.18) (Table 8, Figure 10).
4.3.4 Discriminating sensory impairment
Only stand-sit performance features from the supervised 30CST discriminated
between participants with and without sensory impairment at our thresholds, and
all five of the features consisted of chest acceleration characteristics (Figure 10,
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Table 8). The feature that best discriminated between SI and MSI was the median
of minimum ML acceleration across all 30CST repetitions during the first half of
the st-si phase (Med of min ML accel st-si (1), AUC=0.807, p=0.002, d=1.23, Table
8, Figure 10).

4.4. Discussion
In this study we directly compared the ability of sit-stand and stand-sit
performance metrics to discriminate impairment and fall risk in a relatively low
disability cohort of PwMS during instrumented structured and unstructured tasks
in supervised settings and daily life. Our findings are consistent with recent
findings in gait analysis that group discrimination is optimized by different
features and is context dependent [70]. However, our work also demonstrates the
utility of both unsupervised and supervised monitoring; in our study
unsupervised monitoring during daily life resulted in an improved ability to
discriminate fall risk, yet supervised functional assessments yielded features that
best discriminated between specific impairments related to fall risk (Table 8,
Figure 10). The type (temporal vs acceleration-related) of performance metric,
sensor location (thigh vs chest) and context all influenced the ability to
discriminate between groups. Chest kinematic features outperformed thigh and
temporal features for all supervised 30CST scenarios, however a straightforward
thigh-derived temporal metric outperformed all other performance metrics for
discriminating between high and low fall risk (Figure 10).
The instrumented 30CST as a functional assessment to identify specific
modes of impairment could lead to improved ability to target and individualize
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therapeutic interventions prior to a fall occurring. The original (non-instrumented)
30CST has been historically associated with lower extremity functional strength in
older adults [60,83,112], thus the results of our study are consistent with the 30CST
as an indicator of pyramidal impairment, which includes strength as a component.
Additionally, the 30CST as currently used in the clinical setting may serve to alert
clinicians to functional strength deficits as the gross measure of 30CST
performance (number of repetitions) discriminated between the groups with the
3rd highest AUC and strong effect size (AUC=0.825, p=0.002, d=1.18, Figure 10,
Table 8). Since sensory inputs and biomechanical constraints, which include
strength deficits, are both instrumental to a healthy balance system [8],
instrumented functional assessments could serve to improve clinicians’ accuracy
to target and then intervene on these systems.
Only chest performance metrics during the 1st half of the st-si phase during
supervised 30CSTs met the threshold to discriminate sensory impairment.
Capturing metrics reflective of trunk control in the first half of the st-si transition
agrees with previous studies discriminating fall risk [64] and PwMS from healthy
controls [54]. In particular, differences in the ML and AP components of trunk
acceleration appear to represent deficits in postural control and balance in PwMS
when eccentric control and coordination are required to simultaneously direct the
center of mass caudally and posteriorly to a specific target [54]. Interestingly, a
previous study of gait analysis investigating the use of spatio-temporal gait
parameters to inform sensory/pyramidal impairment were successful in relating
gait dysfunction to pyramidal but not sensory involvement [131]. Thus, task
dependence may play a role in the identification of specific impairments and our
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inclusion of a chest acceleration metric allowed for identifying a potential
movement pattern unique to sensory deficits for all three components (ML, AP,
CC) and all with strong effect sizes (d>1.0, Table 8).
While our previous work demonstrating differences in supervised and
unsupervised 30CST performance could have been influenced by differences in
chair height vs performance variability [129], we illustrate here that simply
monitoring sit-stand time discriminated fall risk with the highest AUC and strong
effect size (Table 8, Figure 10). Monitoring daily life appears to consider the
inherent variability associated with task performance that also increases fall risk,
such as divided attention, fluctuating symptoms, and environmental factors. Thus,
these results demonstrate that a relatively short unsupervised monitoring period
with a single thigh sensor after a clinic visit would be beneficial for detecting fall
risk, while not requiring a more extensive biomechanical analysis during the clinic
visit where time is limited. Conversely, standardized functional tests likely reduce
variability affiliated with fall risk in daily life, but still may prove useful for
detecting underlying mechanisms for disability. Thus, the 30CST, and particularly
an instrumented version, could serve to direct clinicians toward targeted
interventions to improve strength or sensory deficits.
There were several limitations of this study. Our total sample size of 37
participants led to modest group sizes for each cohort. While we identified
features with strong effect sizes, we were not able to achieve any AUC values
greater than 0.90 for discriminating groups. We expected to find accelerometerrelated metrics indicative of lower extremity strength deficits and/or increased
trunk flexion strategies during the sit-stand transition [53], however our relatively
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low disability cohort may have prevented identification of performance that
would generalize to a larger cohort of PwMS. Therefore, future work should
include longitudinal studies from a more diverse cohort including interventions
to target pyramidal and sensory impairment to strengthen the utility of the 30CST
to identify and assess performance metrics to measure change over time. Future
work should also include establishing rigorous psychometric properties in PwMS
similar to work done in other patient populations [112,113].
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Chapter 5: Conclusion

5.1 Summary of contributions
A dataset in a cohort of relatively low disability PwMS (n=40) was collected
that included a group experiencing a fall in the preceding 6-months. The data
comprise wearable inertial sensor data collected during instrumented supervised
(laboratory) and unsupervised (daily life) monitoring. During the laboratory
session disability was quantified with the EDSS and participants completed
multiple patient-reported outcome measures associated with fatigue, balance
confidence, sleep quality and gait. Participants were instrumented bilaterally with
two wearable sensor systems (Biostamp, MC10, Inc., Lexington, MA and Opal,
APDM Wearable Technologies, Portland, OR) and then completed standardized
functional assessments, activities of daily living, and walking trials. Immediately
following the laboratory session, a subset of one sensor system (Biostamp, MC10,
Inc., Lexington, MA) was donned and acceleration data were continuously
collected for approximately two days. During the unsupervised monitoring
participants were asked to perform bi-hourly 30CSTs and rate their balance and
fatigue using Likert Scales, which presented an opportunity to investigate the
variability of performance for the first time of any standardized functional
assessment. This data set represents a comprehensive set of wearable sensor data
to facilitate direct comparisons between laboratory and daily life mobility
performance. These data have already been utilized to explore partnering
laboratory-based gait parameters and deep learning models to predict fall risk
[135], and sleep quality during free-living [136].
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This dataset presents

opportunities for further exploration of gait, balance and activities of daily living
in supervised and unsupervised settings.
The work presented in this dissertation was based only on thigh and chest
acceleration-related data and represents an evaluation of the sit-stand and standsit transitions during structured (30CST) and unstructured (daily life) tasks.
Chapter 2 presented a new method for automatically delineating the phases of the
sit-stand and stand-sit transition using a single thigh sensor and then explored the
30CST as a tool for discriminating fall risk in PwMS using accelerometer-related
performance metrics. Simple accelerometer-based metrics were moderately
correlated with clinically validated measures and were better able to differentiate
fallers from non-fallers than the standard outcome measure of the 30CST. Chapter
3 presented a comparison of supervised and unsupervised performance of the
30CST and characterized variability of performance on bi-hourly 30CSTs over two
days. AUC analysis supported a cutoff threshold of 13 repetitions for the
supervised 30CST to optimize classification of fall status, the first study to provide
a recommended performance threshold in PwMS utilizing the current standard of
care, though accuracy and sensitivity were improved using performance metrics
extracted from a wearable sensor. This study illustrates how wearable sensors
could augment routine clinical exams and inform clinical decision making by
including an unsupervised monitoring period to provide insight into symptom
fluctuation and fall risk during free-living conditions.
Chapter 4 provided insight into differences during supervised and
unsupervised sit-stand performance during structured and unstructured tasks.
The results suggest there are benefits for both supervised (structured) assessments
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and unsupervised (daily life) monitoring of sit-stand and stand-sit transitions.
While average sit-stand time over two days during daily life monitored from a
single thigh sensor best discriminated fall risk in PwMS, performance metrics
derived from chest and thigh sensors during supervised 30CSTs were better
indicators of sensory and pyramidal impairment. Daily life performance may
reflect the multifactorial nature of fall risk while standardized functional tests
provide insight into specific impairments and could be useful for targeted
interventions.

5.2 Other exploratory analyses and recommendations for future work
The data collected during this study were limited to a low relative disability
cohort of PwMS (EDSS < 6.0) due to the inclusion criteria restricting participation
to those not requiring assistive devices or orthotics. Restricting the disability of the
cohort in this manner limited the generalizability of these results, but also resulted
in a relatively young cohort (mean age 50.6 ± 12.3 years, Table 4). While there was
a statistically significant age difference (p=0.008) between fallers (55.2 ± 10.3 years)
and non-fallers (44.7 ± 12.4 years), the faller mean age was well below the age
range reported by literature where fall risk increases (see [137,138] for systematic
reviews). It is not expected that controlling for age as an additional risk factor for
falls would yield different results in this cohort. Future work should include
longitudinal studies from a more diverse cohort, which may also serve to improve
the discriminative ability between groups.
The utility of the instrumented 30CST could be enhanced in multiple ways.
First, a concurrent validation of wearable sensor metrics with traditional
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biomechanical methods (i.e., force plate, motion analysis, EMG) in healthy agematched adults to assign physiological significance would improve the
interpretability of performance metrics. Comparing performance of PwMS and
healthy adults would allow for further insight into impairment and/or
compensatory strategies employed by PwMS, providing a foundation for
intervention studies targeting specific impairments. Evaluating change of
performance metrics over time, to both disease progression (negative change) and
response to interventions (positive change) would then facilitate a sensitivity
analysis to identify the performance metrics most informative for monitoring
changes due to disease progression and/or intervention strategies. A randomized
controlled interventional study targeting balance, pyramidal and sensory
impairment could provide physical therapists with objective, quantifiable metrics
for evaluating intervention efficacy and fall risk. Future work should also include
establishing rigorous psychometric properties of the 30CST in PwMS similar to
work done in other patient populations [112,113].
As sensorimotor deficits are often asymmetrical in PwMS [14,139], this
dataset was used to explore the ability of acceleration-related laboratory-based
performance metrics to predict the lower extremity most impaired in the sensory
and pyramidal domains. The discriminative ability was poor to detect differences
between the limbs and it was determined that either (1) the instrumented 30CST
was not an appropriate functional task to explore these differences or (2) the
metrics thus far developed were not sensitive to detect differences between the
limbs in these domains. It is hypothesized that use of gait measures could lead to
improved sensitivity for identification of unilateral impairments.
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While machine learning techniques were employed in Chapter 2 to explore
their utility for discriminating high and low fall risk and outperformed the
standard of care [111], the AUC of models using this approach was lower than
expected. Using summary metrics as model inputs yielded one observation per
participant per metric and subsequently limited the number of allowable model
inputs. It was theorized that model performance could be improved by increasing
the observations per participant that would allow for more model parameters.
Thus, machine learning based approaches were investigated using similar metrics
computed for each individual 30CST repetition from supervised and
unsupervised 30CSTs, which significantly increased the number of observations
to over 400 in the case of unsupervised 30CSTs. However, machine learning
models utilizing unsupervised observations reflective of individual repetition
performance failed to outperform the original analysis. While >400 observations
were a significant increase, it is likely the number of observations and/or
performance metrics were insufficient for characterizing the amount of variability
inherent in daily life performance. The ROC analyses of Chapters 3 and 4 resulted
from these findings as alternative means were pursued for discriminating between
groups. The intent of this work was to develop acceleration-related (and not
gyroscopic) metrics with plausible physiological relevance as opposed to methods
where interpretation may further limit clinical utility [140]. Thus, an exploration
of deep learning and other signal features not limited by potential physiological
interpretation could yield improved machine learning model performance, as well
as inclusion of gyroscopic features.
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Finally, the demonstrated ability to delineate the phases of the sit-stand and
stand-sit using only the accelerometer signal from a single thigh sensor (Chapter
2) implies that the accelerometer (and/or gyroscopic) signal capability within
mobile phones could be leveraged to develop a mobile application for use in the
clinic and community settings. To explore the feasibility, a prototype 30CST
application was developed in conjunction with a computer science Android
application development class. A group of computer science successfully
delivered a basic framework and interface for a smartphone app that recorded
accelerometer data during a 30CST with a mobile phone located in the pocket or
fixed to the thigh with an elastic band. Incorporating performance metrics into the
algorithm and validating the mobile phone application algorithm with an inertial
sensor placed on the thigh could lead to a widely available application for use in
clinical settings.

5.3 Barriers to clinical adoption
While the work presented here and by other inertial sensor studies is
compelling, there remain barriers to clinical adoption of engineering solutions,
including inertial sensor driven approaches, to evaluate impairment and inform
care. These barriers are primarily entrenched in the ways in which we equip
clinicians to care for patients and train engineers to create solutions for clinicians.
While medical training paradigms outside of the United States (US) require
formalized interdisciplinary learning opportunities for medical students, there are
no such requirements in US medical and engineering training [141]. The reality of
our current training paradigm across engineering and medical disciplines
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produces an endless cycle where university departments are both producers and
consumers of academic professionals with little incentive to deviate from
established discipline-specific silos [142]. Further, “institutional elements (e.g.,
actions, roles, structures) are resistant to change, are maintained without justification for
long periods of time, and are easily transmittable to new organizational members [142].”
Medical students are significantly less likely to realize the value in
interdisciplinary learning [with engineering students] and the importance of
fostering creativity which improves problem solving, patient satisfaction and
treatment outcomes [141]. Creativity training programs in the medical curriculum
that lead to measurable changes in divergent thinking and flexibility require 20-30
contact hours including instructor led, challenging, real-world cases [143,144]. In
the case of physical therapy training, students should be introduced to
sophisticated alternative instrumentation during the course of their formal
training to augment their decision making if we are to expect the incorporation of
more complex tools into their future clinical practice.
Conversely, engineers do not prioritize or recognize the necessity of
understanding the clinician workflow. Clinicians are limited by the time available
to conduct complex assessments and often rely on self-report or simple
assessments to screen for risk factors of interest and direct intervention [39,41,42].
Even adding five-minutes to a clinical evaluation to place instrumentation and
collect data create a barrier given the typical expectations for the number of
patients a clinician must treat on a clinic day. The additional data interpretation
and documentation requirements for any assessment necessitates tools and
processes that are truly streamlined, intuitive and automated. Equipment that is
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freely available (i.e., mobile phone applications) are more likely to be adopted
given the financial barriers of acquiring and training clinicians to use any
technology. Thus, there will remain significant barriers to the adoption of
wearable technologies to inform patient care until these obstacles are addressed in
the way we train and produce students of allied health professions and
engineering. Biomedical engineering training programs would benefit from
understanding how to characterize clinical workflow, similar to methods
employed by industrial engineering process work-flow approaches.
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